Encompass Health (EHC) 10-Q28 Apr 162015 Q1 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($) $ in Billions	3 Months Ended
Document and Entity Information - USD ($) $ in Billions	Mar. 31, 2016	Apr. 20, 2016	Jun. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	HEALTHSOUTH CORP
Entity Central Index Key	785,161
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		90,014,022
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 4

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Net operating revenues	$ 909.8	$ 740.6
Less: Provision for doubtful accounts	(16.5)	(11.6)
Net operating revenues less provision for doubtful accounts	893.3	729
Operating expenses:
Salaries and benefits	486.1	385.1
Other operating expenses	119.2	103.2
Occupancy costs	18	12.1
Supplies	35	31.4
General and administrative expenses	31.9	34.6
Depreciation and amortization	42.4	31.9
Government, class action, and related settlements	0	8
Professional fees - accounting, tax, and legal	0.2	2.2
Total operating expenses	732.8	608.5
Loss on early extinguishment of debt	2.4	1.2
Interest expense and amortization of debt discounts and fees	44.6	31.8
Other income	(0.6)	(0.5)
Equity in net income of nonconsolidated affiliates	(2.4)	(1.6)
Income from continuing operations before income tax expense	116.5	89.6
Provision for income tax expense	39.7	30.3
Income from continuing operations	76.8	59.3
Loss from discontinued operations, net of tax	(0.1)	(0.3)
Net income	76.7	59
Less: Net income attributable to noncontrolling interests	(18.7)	(16.5)
Net income attributable to HealthSouth	58	42.5
Less: Convertible perpetual preferred stock dividends	0	(1.6)
Net income attributable to HealthSouth common shareholders	$ 58	$ 40.9
Weighted average common shares outstanding:
Basic	89.5	87.1
Diluted	99.4	101.1
Basic earnings per share attributable to HealthSouth common shareholders:
Continuing operations	$ 0.65	$ 0.47
Discontinued operations	0	0
Net Income	0.65	0.47
Diluted earnings per share attributable to HealthSouth common shareholders:
Continuing operations	0.61	0.44
Discontinued operations	0	0
Net income	0.61	0.44
Cash dividends per common share	$ 0.23	$ 0.21
Amounts attributable to HealthSouth common shareholders:
Income from continuing operations	$ 58.1	$ 42.8
Loss from discontinued operations, net of tax	(0.1)	(0.3)
Net income attributable to HealthSouth	$ 58	$ 42.5

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
COMPREHENSIVE INCOME
Net income	$ 76.7	$ 59
Net change in unrealized gain on available-for-sale securities:
Unrealized net holding gain arising during the period	0.2	0.1
Other comprehensive income before income taxes	0.2	0.1
Provision for income tax benefit related to other comprehensive income items	(0.1)	0
Other comprehensive income, net of tax	0.1	0.1
Comprehensive income	76.8	59.1
Comprehensive income attributable to noncontrolling interests	(18.7)	(16.5)
Comprehensive income attributable to HealthSouth	$ 58.1	$ 42.6

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions	Mar. 31, 2016		Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 73.2		$ 61.6	$ 208.3	$ 66.7
Accounts receivable, net of allowance for doubtful accounts of $44.7 in 2016; $39.3 in 2015	431.9		410.5
Other current assets	127		126.6
Total current assets	632.1		598.7
Property and equipment, net	1,317.7		1,310.1
Goodwill	1,891.9		1,890.1
Intangible assets, net	415.8		419.4
Deferred income tax assets	145		190.8
Other long-term assets	205.8		197
Total assets	4,608.3	[1]	4,606.1
Current liabilities:
Current portion of long-term debt	36.6		36.8
Accounts payable	62.7		61.6
Accrued expenses and other current liabilities	364.5		328
Total current liabilities	463.8		426.4
Long-term debt, net of current portion	3,079.6		3,134.7
Other long-term liabilities	144.8		144.6
Total Liabilities	$ 3,688.2		$ 3,705.7
Commitments and contingencies
Redeemable noncontrolling interests	$ 96.2		$ 121.1
Shareholders' equity:
HealthSouth shareholders’ equity	649.5		611.4
Noncontrolling interests	174.4		167.9
Total shareholders' equity	823.9		779.3	$ 640.4	$ 619.5
Total liabilities and shareholders' equity	$ 4,608.3	[1]	$ 4,606.1

[1]	(1) Our consolidated assets as of March 31, 2016 include total assets of variable interest entities of $247.3 million, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of March 31, 2016 include total liabilities of the variable interest entities of $54.0 million. See Note 3, Variable Interest Entities.

Condensed Consolidated Balance5

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 44.7	$ 39.3
Total assets of variable interest entities	247.3
Total liabilities of variable interest entities	$ 54

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Capital in Excess of Par Value	Accumulated Deficit	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2014	$ 619.5	$ 1	$ 2,810.5	$ (1,879.1)	$ (0.5)	$ (458.7)	$ 146.3
Balance at beginning of period, Shares at Dec. 31, 2014		87.8
Net income	42.5			42.5
Net income attributable to nonredeemable noncontrolling interest	13.6						13.6
Net income, including portion attributable to nonredeemable noncontrolling interest, total	56.1
Receipt of treasury stock	(14.9)					(14.9)
Receipt of treasury stock, Shares		(0.5)
Dividends declared on common stock	(18.7)		(18.7)
Dividends declared on convertible perpetual preferred stock	(1.6)		(1.6)
Stock-based compensation	9.1		9.1
Stock options exercised	1.9		5.5			(3.6)
Stock options exercised, Shares		0.2
Distributions declared	(12.4)						(12.4)
Other	1.4		0.8		0.1	(0.1)	0.6
Other, Shares		0.7
Balance at end of period at Mar. 31, 2015	640.4	$ 1	2,805.6	(1,836.6)	(0.4)	(477.3)	148.1
Balance at end of period, Shares at Mar. 31, 2015		88.2
Balance at beginning of period at Dec. 31, 2015	779.3	$ 1.1	2,834.9	(1,696)	(1.2)	(527.4)	167.9
Balance at beginning of period, Shares at Dec. 31, 2015		90.1
Net income	58			58
Net income attributable to nonredeemable noncontrolling interest	14.8						14.8
Net income, including portion attributable to nonredeemable noncontrolling interest, total	72.8
Receipt of treasury stock	(9.9)					(9.9)
Receipt of treasury stock, Shares		(0.4)
Dividends declared on common stock	(20.8)		(20.8)
Stock-based compensation	5.9		5.9
Stock options exercised	0.4		5			(4.6)
Stock options exercised, Shares		0.2
Distributions declared	(17.1)						(17.1)
Capital contributions from consolidated affiliates	7.4						7.4
Fair value adjustments to redeemable noncontrolling interests, net of tax	16.3		16.3
Repurchases of common stock	(12.9)					(12.9)
Repurchases of common stock, Shares		(0.4)
Other	2.5	$ 0	1.2		0.1	(0.2)	1.4
Other, Shares		0.5
Balance at end of period at Mar. 31, 2016	$ 823.9	$ 1.1	$ 2,842.5	$ (1,638)	$ (1.1)	$ (555)	$ 174.4
Balance at end of period, Shares at Mar. 31, 2016		90

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net income	$ 76.7	$ 59
Loss from discontinued operations, net of tax	(0.1)	(0.3)
Adjustments to reconcile net income to net cash provided by operating activities-
Provision for doubtful accounts	16.5	11.6
Depreciation and amortization	42.4	31.9
Equity in net income of nonconsolidated affiliates	(2.4)	(1.6)
Distributions from nonconsolidated affiliates	1.7	1.9
Stock-based compensation	4.5	9.4
Deferred tax expense	34.7	26.8
Other	5.9	10.8
Change in assets and liabilities-
Accounts receivable	(45.7)	(37.3)
Other assets	1.8	(2.9)
Accounts payable	0.6	2.1
Accrued payroll	20.9	(23.3)
Other liabilities	4.1	5.4
Premium received on bond issuance	0	8
Premium paid on redemption of bonds	(1.9)	0
Net cash used in operating activities of discontinued operations	(0.2)	(0.1)
Total adjustments	82.9	42.7
Net cash provided by operating activities	159.7	102
Cash flows from investing activities:
Purchases of property and equipment	(31.4)	(17.7)
Capitalized software costs	(7.7)	(8.9)
Acquisition of business, net of cash acquired	0	(7.3)
Net change in restricted cash	(3.2)	(15)
Other	2.8	3.2
Net cash used in investing activities	(39.5)	(45.7)
Cash flows from financing activities:
Proceeds from bond issuance	0	700
Principal payments on debt, including pre-payments	(56.3)	(252.9)
Borrowings on revolving credit facility	60	35
Payments on revolving credit facility	(60)	(350)
Debt amendment and issuance costs	0	(13.7)
Repurchase of common stock, including fees and expenses	(12.9)	0
Dividends paid on common stock	(21.3)	(18.6)
Dividends paid on convertible perpetual preferred stock	0	(1.6)
Distributions paid to noncontrolling interests of consolidated affiliates	(15.6)	(13.2)
Other	(2.5)	0.3
Net cash (used in) provided by financing activities	(108.6)	85.3
Increase in cash and cash equivalents	11.6	141.6
Cash and cash equivalents at beginning of period	61.6	66.7
Cash and cash equivalents at end of period	$ 73.2	$ 208.3

Basis of Presentation

Basis of Presentation	3 Months Ended
Basis of Presentation	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation HealthSouth Corporation, incorporated in Delaware in 1984, including its subsidiaries, is one of the nation’s largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 34 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. The accompanying unaudited condensed consolidated financial statements of HealthSouth Corporation and Subsidiaries should be read in conjunction with the consolidated financial statements and accompanying notes filed with the United States Securities and Exchange Commission in HealthSouth’s Annual Report on Form 10-K filed on February 24, 2016 (the “ 2015 Form 10-K”). The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC applicable to interim financial information. Certain information and note disclosures included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been omitted in these interim statements, as allowed by such SEC rules and regulations. The condensed consolidated balance sheet as of December 31, 2015 has been derived from audited financial statements, but it does not include all disclosures required by GAAP. However, we believe the disclosures are adequate to make the information presented not misleading. The unaudited results of operations for the interim periods shown in these financial statements are not necessarily indicative of operating results for the entire year. In our opinion, the accompanying condensed consolidated financial statements recognize all adjustments of a normal recurring nature considered necessary to fairly state the financial position, results of operations, and cash flows for each interim period presented. See also Note 12 , Segment Reporting . Variable Interest Entities — Effective January 1, 2016, in connection with our adoption of ASU 2015-02, we updated our evaluation of all jointly held legal entities to determine whether they are now variable interest entities (“VIEs”) under the new guidance. Any entity considered a VIE is evaluated to determine which party is the primary beneficiary and thus should consolidate the VIE. This analysis is complex, involves uncertainties, and requires significant judgment on various matters. In order to determine if we are the primary beneficiary of a VIE, we must determine what activities most significantly impact the economic performance of the entity, whether we have the power to direct those activities, and if our obligation to absorb losses or receive benefits from the VIE could potentially be significant to the VIE. Net Operating Revenues — We derived consolidated Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 75.4 % 74.9 % Medicare Advantage 7.8 % 8.2 % Managed care 9.5 % 10.0 % Medicaid 3.4 % 2.6 % Other third-party payors 1.4 % 1.5 % Workers’ compensation 0.9 % 0.9 % Patients 0.5 % 0.7 % Other income 1.1 % 1.2 % Total 100.0 % 100.0 % Inpatient Rehabilitation Revenues Our inpatient rehabilitation segment derived its Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 73.8 % 73.5 % Medicare Advantage 7.6 % 8.3 % Managed care 11.0 % 11.2 % Medicaid 3.0 % 2.0 % Other third-party payors 1.6 % 1.7 % Workers’ compensation 1.1 % 1.1 % Patients 0.6 % 0.8 % Other income 1.3 % 1.4 % Total 100.0 % 100.0 % Home Health and Hospice Revenues Our home health and hospice segment derived its Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 83.5 % 83.8 % Medicare Advantage 8.7 % 7.3 % Managed care 2.7 % 3.1 % Medicaid 4.9 % 5.6 % Other third-party payors — % 0.1 % Patients 0.1 % 0.1 % Other income 0.1 % — % Total 100.0 % 100.0 % See Note 1, Summary of Significant Accounting Policies , to the consolidated financial statements accompanying the 2015 Form 10-K for our policies related to Net operating revenues , Accounts receivable , and our Allowance for doubtful accounts. Recent Accounting Pronouncements — In February 2015, the FASB issued ASU 2015-02, “Consolidations (Topic 810) - Amendments to the Consolidation Analysis,” which provides guidance on evaluating whether a reporting entity should consolidate certain legal entities. Specifically, the amendments modify the evaluation of whether limited partnerships and similar legal entities are VIEs. Under this analysis, limited partnerships and other similar entities will be considered a VIE unless the limited partners hold substantive kick-out rights or participating rights. Further, the amendments eliminate the presumption that a general partner should consolidate a limited partnership under the voting interest model, as well as affect the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships. This standard was effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. We elected to adopt this guidance using the modified retrospective approach. Our adoption of this guidance resulted in certain limited partnership-like entities that were previously consolidated as voting interest entities to now be consolidated as VIEs, for which additional disclosures are required. Our adoption of ASU 2015-02 did not have a material impact on our financial position, results of operations, or cash flows. See Note 3 , Variable Interest Entities . In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842),” in order to increase transparency and comparability by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new standard, lessees will recognize a right-of-use asset and a corresponding lease liability for all leases other than leases that meet the definition of a short-term lease. The liability will be equal to the present value of lease payments. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Operating leases will result in straight-line expense while finance leases will result in an expense pattern similar to current capital leases. Classification will be based on criteria that are similar to those applied in current lease accounting. This standard will be effective for HealthSouth for the annual reporting period beginning after December 15, 2018. Early adoption is permitted. We continue to review the requirements of this standard and any potential impact it may have on our financial position, results of operations, or cash flows. In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting (Topic 718),” to simplify various aspects of share-based payment accounting and presentation. The new standard requires entities to record all of the tax effects related to share-based payments at settlement (or expiration) through the income statement. This will require us to reclassify tax benefits in excess of compensation cost (“windfalls”) and tax deficiencies (“shortfalls”) to the extent of previous windfalls from Capital in excess of par value to Provision for income tax expense . This change is required to be applied prospectively to all excess tax benefits and tax deficiencies resulting from settlements after the date of adoption of the ASU. The standard eliminates the requirement to delay recognition of a windfall tax benefit until it reduces current taxes payable. This change is required to be applied on a modified retrospective basis, with a cumulative-effect adjustment to opening retained earnings. In addition, all income tax-related cash flows resulting from share-based payments are required to be reported as operating activities on the statement of cash flows as opposed to the current presentation as an inflow from financing activities and an outflow from operating activities. Either prospective or retrospective transition of this provision is permitted. Finally, the standard clarifies that all cash payments made to taxing authorities on the employees’ behalf for withheld shares should be presented as financing activities on the statement of cash flows. This change will be applied retrospectively. For public companies, this guidance is effective for annual reporting periods beginning after December 15, 2016 and interim periods within that reporting period. Early adoption is permitted, with any adjustments reflected as of the beginning of the fiscal year of adoption. We continue to review the requirements of this standard and any potential impact it may have on our financial position, results of operations, or cash flows.

Business Combinations

Business Combinations	3 Months Ended
Business Combinations	Mar. 31, 2016
Business Combinations [Abstract]
Business Combinations	Business Combinations In February 2016, we acquired 50% of the inpatient rehabilitation hospital at CHI St. Vincent Hot Springs (“Hot Springs”), a 20 -bed inpatient rehabilitation hospital in Hot Springs, Arkansas, through a joint venture with St. Vincent Community Health Services, Inc. The acquisition, which was funded through a contribution to the consolidated joint venture, was not material to our financial position, results of operations, or cash flows. The Hot Springs transaction was made to enhance our position and ability to provide inpatient rehabilitative services to patients in Hot Springs and its surrounding areas. As a result of this transaction, Goodwill increased by $1.8 million , none of which is deductible for federal income tax purposes. The goodwill reflects our expectations of our ability to gain access to and penetrate the acquired hospital’s historical patient base and the benefits of being able to leverage operational efficiencies with favorable growth opportunities based on positive demographic trends in this market. We accounted for this transaction under the acquisition method of accounting and reported the results of operations of the acquired hospital from its respective date of acquisition. Assets acquired and liabilities assumed, if any, were recorded at their estimated fair values as of the respective acquisition date. The fair value of the identifiable intangible asset was based on valuations using the income approach. The income approach is based on management’s estimates of future operating results and cash flows discounted using a weighted-average cost of capital that reflects market participant assumptions. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired was recorded as goodwill. The fair value of the assets acquired at the acquisition date were as follows (in millions): Property and equipment $ 5.1 Identifiable intangible asset: Trade name (useful life of 20 years) 0.2 Goodwill 1.8 Total assets acquired $ 7.1 Information regarding the net cash paid was as follows (in millions): Three Months Ended March 31, 2016 Fair value of assets acquired $ 5.3 Goodwill 1.8 Fair value of noncontrolling interest owned by joint venture partner (7.1 ) Net cash paid for acquisition $ — Pro Forma Results of Operations The following table summarizes the results of operations of the above mentioned transaction from its respective date of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisition been January 1, 2015 (in millions): Net Operating Revenues Net Income Attributable to HealthSouth Acquired entities only: Actual from acquisition date to March 31, 2016 $ 0.3 $ (0.7 ) Combined entity: Supplemental pro forma from 01/01/2016-03/31/2016 910.1 58.0 Combined entity: Supplemental pro forma from 01/01/2015-03/31/2015 741.6 42.6 See Note 2, Business Combinations , to the consolidated financial statements accompanying the 2015 Form 10-K for information regarding acquisitions completed in 2015.

Variable Interest Entities Vari

Variable Interest Entities Variable Interest Entities	3 Months Ended
Variable Interest Entities Variable Interest Entities	Mar. 31, 2016
Variable Interest Entities [Abstract]
Variable Interest Entity Disclosure [Text Block]	Variable Interest Entities As of March 31, 2016, we consolidated ten limited partnership-like entities that are VIEs and of which we are the primary beneficiary. All ten of these entities were also consolidated as of December 31, 2015. Our ownership percentages in these entities range from 6.8% to 99.5% . Through partnership and management agreements with or governing each of these entities, we manage all of these entities and handle all day-to-day operating decisions. Accordingly, we have the decision making power over the activities that most significantly impact the economic performance of our VIEs and an obligation to absorb losses or receive benefits from the VIE that could potentially be significant to the VIE. These decisions and significant activities include, but are not limited to, marketing efforts, oversight of patient admissions, medical training, nurse and therapist scheduling, provision of healthcare services, billing, collections and creation and maintenance of medical records. The terms of the agreements governing each of our VIEs prohibit us from using the assets of each VIE to satisfy the obligations of other entities. The carrying amounts and classifications of the consolidated VIEs’ assets and liabilities, which are included in our consolidated balance sheet, are as follows (in millions): March 31, 2016 Assets Current assets: Cash and cash equivalents $ 1.6 Accounts receivable, net of allowance for doubtful accounts 28.9 Other current assets 6.4 Total current assets 36.9 Property and equipment, net 126.8 Goodwill 73.5 Intangible assets, net 9.2 Other long-term assets 0.9 Total assets $ 247.3 Liabilities Current liabilities: Current portion of long-term debt $ 1.4 Accounts payable 7.5 Accrued expenses and other current liabilities 14.2 Total current liabilities 23.1 Long-term debt, net of current portion 30.9 Total liabilities $ 54.0

Investments in and Advances to

Investments in and Advances to Nonconsolidated Affiliates	3 Months Ended
Investments in and Advances to Nonconsolidated Affiliates	Mar. 31, 2016
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Abstract]
Investments in and Advances to Nonconsolidated Affiliates	Investments in and Advances to Nonconsolidated Affiliates As of March 31, 2016 and December 31, 2015 , we had $12.5 million and $11.7 million , respectively, of investments in and advances to nonconsolidated affiliates included in Other long-term assets in our condensed consolidated balance sheets. Investments in and advances to nonconsolidated affiliates represent our investments in seven partially owned subsidiaries, of which six are general or limited partnerships, limited liability companies, or joint ventures in which HealthSouth or one of its subsidiaries is a general or limited partner, managing member, member, or venturer, as applicable. We do not control these affiliates but have the ability to exercise significant influence over the operating and financial policies of certain of these affiliates. Our ownership percentages in these affiliates range from approximately 1% to 60% . We account for these investments using the cost and equity methods of accounting. The following summarizes the combined results of operations of our equity method affiliates (on a 100% basis, in millions): Three Months Ended March 31, 2016 2015 Net operating revenues $ 11.2 $ 8.2 Operating expenses (3.2 ) (3.9 ) Income from continuing operations, net of tax 5.0 3.9 Net income 5.0 3.9

Long-term Debt

Long-term Debt	3 Months Ended
Long-term Debt	Mar. 31, 2016
Debt Disclosure [Abstract]
Long-term Debt	Long-term Debt Our long-term debt outstanding consists of the following (in millions): March 31, 2016 December 31, 2015 Credit Agreement— Advances under revolving credit facility $ 130.0 $ 130.0 Term loan facilities 437.8 443.3 Bonds payable— 7.75% Senior Notes due 2022 124.8 174.3 5.125% Senior Notes due 2023 294.8 294.6 5.75% Senior Notes due 2024 1,192.7 1,192.6 5.75% Senior Notes due 2025 343.5 343.4 2.00% Convertible Senior Subordinated Notes due 2043 268.3 265.9 Other notes payable 38.4 39.2 Capital lease obligations 285.9 288.2 3,116.2 3,171.5 Less: Current portion (36.6 ) (36.8 ) Long-term debt, net of current portion $ 3,079.6 $ 3,134.7 The following chart shows scheduled principal payments due on long-term debt for the next five years and thereafter (in millions): Face Amount Net Amount April 1 through December 31, 2016 $ 27.8 $ 27.8 2017 36.5 36.5 2018 36.6 36.6 2019 39.6 39.6 2020 813.7 760.4 2021 10.1 10.1 Thereafter 2,225.4 2,205.2 Total $ 3,189.7 $ 3,116.2 On February 23, 2016, we gave notice of, and made an irrevocable commitment for, the redemption of $50 million of the outstanding principal amount of our existing 7.75% Senior Notes due 2022 (the “2022 Notes”). On March 24, 2016 , we completed this redemption using cash on hand and capacity under our revolving credit facility. Pursuant to the terms of the 2022 Notes, this optional redemption was made at a price of 103.875% , which resulted in a total cash outlay of approximately $52 million . As a result of this redemption, we recorded a $2.4 million Loss on early extinguishment of debt in the first quarter of 2016. On April 6, 2016, we gave notice of, and made an irrevocable commitment for, the redemption of an additional $50 million of the outstanding principal amount of the 2022 Notes. This optional redemption also will be made at a price of 103.875% , which will result in a total cash outlay of approximately $52 million when the transaction closes on May 6, 2016. We plan to use cash on hand and capacity under our revolving credit facility to fund the redemption. As a result of this redemption, we expect to record an approximate $2 million loss on early extinguishment of debt in the second quarter of 2016. For additional information regarding our indebtedness, see Note 8, Long-term Debt, to the consolidated financial statements accompanying the 2015 Form 10-K.

Redeemable Noncontrolling Inter

Redeemable Noncontrolling Interests	3 Months Ended
Redeemable Noncontrolling Interests	Mar. 31, 2016
Redeemable Noncontrolling Interests [Abstract]
Redeemable Noncontolling Interests	Redeemable Noncontrolling Interests The following is a summary of the activity related to our Redeemable noncontrolling interests during the three months ended March 31, 2016 and 2015 (in millions): Three Months Ended March 31, 2016 2015 Balance at beginning of period $ 121.1 $ 84.7 Net income attributable to noncontrolling interests 3.9 2.9 Distributions declared (2.1 ) (1.7 ) Change in fair value (26.7 ) (1.2 ) Balance at end of period $ 96.2 $ 84.7 The following table reconciles the net income attributable to nonredeemable Noncontrolling interests , as recorded in the shareholders’ equity section of the condensed consolidated balance sheets, and the net income attributable to Redeemable noncontrolling interests , as recorded in the mezzanine section of the condensed consolidated balance sheets, to the Net income attributable to noncontrolling interests presented in the condensed consolidated statements of operations for the three months ended March 31, 2016 and 2015 (in millions): Three Months Ended March 31, 2016 2015 Net income attributable to nonredeemable noncontrolling interests $ 14.8 $ 13.6 Net income attributable to redeemable noncontrolling interests 3.9 2.9 Net income attributable to noncontrolling interests $ 18.7 $ 16.5

Fair Value Measurements

Fair Value Measurements	3 Months Ended
Fair Value Measurements	Mar. 31, 2016
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Our financial assets and liabilities that are measured at fair value on a recurring basis are as follows (in millions): Fair Value Measurements at Reporting Date Using As of March 31, 2016 Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Valuation Technique (1) Other current assets: Current portion of restricted marketable securities $ 16.0 $ — $ 16.0 $ — M Other long-term assets: Restricted marketable securities 40.7 — 40.7 — M Redeemable noncontrolling interests 96.2 — — 96.2 I As of December 31, 2015 Other current assets: Current portion of restricted marketable securities $ 16.1 $ — $ 16.1 $ — M Other long-term assets: Restricted marketable securities 40.1 — 40.1 — M Redeemable noncontrolling interests 121.1 — — 121.1 I (1) The three valuation techniques are: market approach (M), cost approach (C), and income approach (I). The fair values of our financial assets and liabilities are determined as follows: • Restricted marketable securities - The fair values of our available-for-sale restricted marketable securities are determined based on quoted market prices in active markets or quoted prices, dealer quotations, or alternative pricing sources supported by observable inputs in markets that are not considered to be active. • Redeemable noncontrolling interests - The fair value of the Redeemable noncontrolling interest related to our home health segment is determined using the product of a twelve-month specified performance measure and a specified median market price multiple based on a basket of public health companies. To determine the fair value of the Redeemable noncontrolling interests in our joint venture hospitals, we use the applicable hospitals’ projected operating results and cash flows discounted using a rate that reflects market participant assumptions for the applicable facilities. The projected operating results use management’s best estimates of economic and market conditions over the forecasted periods including assumptions for pricing and volume, operating expenses, and capital expenditures. See also Note 6 , Redeemable Noncontrolling Interests . In addition to assets and liabilities recorded at fair value on a recurring basis, we are also required to record assets and liabilities at fair value on a nonrecurring basis. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges or similar adjustments made to the carrying value of the applicable assets. During the three months ended March 31, 2016 and March 31, 2015 , we did not record any gains or losses related to our nonfinancial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a nonrecurring basis as part of our continuing operations. As discussed in Note 1, Summary of Significant Accounting Policies , “Fair Value Measurements,” to the consolidated financial statements accompanying the 2015 Form 10-K, the carrying value equals fair value for our financial instruments that are not included in the table below and are classified as current in our condensed consolidated balance sheets. The carrying amounts and estimated fair values for all of our other financial instruments are presented in the following table (in millions): As of March 31, 2016 As of December 31, 2015 Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value Long-term debt: Advances under revolving credit facility $ 130.0 $ 130.0 $ 130.0 $ 130.0 Term loan facilities 437.8 439.4 443.3 445.0 7.75% Senior Notes due 2022 124.8 131.5 174.3 183.7 5.125% Senior Notes due 2023 294.8 298.9 294.6 288.0 5.75% Senior Notes due 2024 1,192.7 1,218.0 1,192.6 1,146.0 5.75% Senior Notes due 2025 343.5 351.8 343.4 332.5 2.00% Convertible Senior Subordinated Notes due 2043 268.3 358.2 265.9 345.0 Other notes payable 38.4 38.4 39.2 39.2 Financial commitments: Letters of credit — 35.0 — 34.2 Fair values for our long-term debt and financial commitments are determined using inputs, including quoted prices in nonactive markets, that are observable either directly or indirectly, or Level 2 inputs within the fair value hierarchy. See Note 1, Summary of Significant Accounting Policies , “Fair Value Measurements,” to the consolidated financial statements accompanying the 2015 Form 10-K.

Share-Based Payments

Share-Based Payments	3 Months Ended
Share-Based Payments	Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based Payments	Share-Based Payments In February 2016, we issued a total of 0.7 million restricted stock awards to members of our management team. Approximately 0.2 million of these awards contain only a service condition, while the remainder contain both a service and a performance or market condition. For the awards that include a performance or market condition, the number of shares that will ultimately be granted to employees may vary based on the Company’s performance during the applicable two-year performance measurement period. Additionally, in February 2016, we granted 0.1 million stock options to members of our management team. The fair value of these awards and options was determined using the policies described in Note 1, Summary of Significant Accounting Policies , and Note 13, Share-Based Payments , to the consolidated financial statements accompanying the 2015 Form 10-K.

Income Taxes

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our Provision for income tax expense of $39.7 million and $30.3 million for the three months ended March 31, 2016 and 2015 , respectively, primarily resulted from the application of our estimated effective blended federal and state income tax rate. The $145.0 million of net deferred tax assets included in the accompanying condensed consolidated balance sheet as of March 31, 2016 reflects management’s assessment it is more likely than not we will be able to generate sufficient future taxable income to utilize those deferred tax assets based on our current estimates and assumptions. As of March 31, 2016 , we maintained a valuation allowance o f $27.6 million due to uncertainties regarding our ability to utilize a portion of our state net operating losses (“NOLs”) and other credits before they expire. The amount of the valuation allowance has been determined for each tax jurisdiction based on the weight of all available evidence including management’s estimates of taxable income for each jurisdiction in which we operate over the periods in which the related deferred tax assets will be recoverable. It is possible we may be required to increase or decrease our valuation allowance at some future time if our forecast of future earnings varies from actual results on a consolidated basis or in the applicable state tax jurisdictions, or if the timing of future tax deductions differs from our expectations. We have significant federal and state NOLs that expire in various amounts at varying times through 2031 . Our reported federal NOL of $64.1 million (approximately $183 million o n a gross basis) as of March 31, 2016 exclud es $15.5 million related to operating loss carryforwards resulting from excess tax benefits related to share-based awards, the tax benefits of which, when recognized, will be accounted for as a credit to Capital in excess of par value when they reduce taxes payable. At March 31, 2016, we had unused federal tax credit carryforwards of $15.0 million . These credit carryforwards expire in various amounts at various times through 2036. Total remaining gross unrecognized tax benefits w ere $3.0 million and $2.9 million as of March 31, 2016 and December 31, 2015 , respectively, all of which would affect our effective tax rate if recognized. A reconciliation of the beginning and ending liability for unrecognized tax benefits is as follows (in millions): Gross Unrecognized Income Tax Benefits Balance at December 31, 2015 $ 2.9 Gross amount of increases in unrecognized tax benefits related to current periods 0.1 Balance at March 31, 2016 $ 3.0 Our continuing practice is to recognize interest and penalties related to income tax matters in income tax expense. Interest recorded as part of our income tax provision during the three months ended March 31, 2016 and 2015 was not material . Accrued interest income related to income taxes as of March 31, 2016 and December 31, 2015 was not material. In December 2014, we signed an agreement with the IRS to begin participating in their Compliance Assurance Process, a program in which we and the IRS endeavor to agree on the treatment of significant tax positions prior to the filing of our federal income tax return. We signed a new agreement in December 2015 for the 2016 tax year. As a result of these agreements, the IRS surveyed our 2013, 2012, and 2011 federal income tax returns and will examine our 2015 and 2016 returns when filed. Our 2014 federal income tax return has been filed, and the IRS has not indicated its intent to examine or survey this return. The IRS is also separately examining the 2013 return of one of our partnership affiliates acquired in the CareSouth transaction. We have settled federal income tax examinations with the IRS for all tax years through 2012. Our state income tax returns are also periodically examined by various regulatory taxing authorities. We are currently under audit by seven states for tax years ranging from 2007 through 2014. For the tax years that remain open under the applicable statutes of limitation, amounts related to unrecognized tax benefits have been considered by management in its estimate of our potential net recovery of prior years’ income taxes. Based on discussions with taxing authorities, we anticipate $0.5 million to $2.9 million of our unrecognized tax benefits may be released within the next 12 months.

Earnings per Common Share

Earnings per Common Share	3 Months Ended
Earnings per Common Share	Mar. 31, 2016
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts): Three Months Ended March 31, 2016 2015 Basic: Numerator: Income from continuing operations $ 76.8 $ 59.3 Less: Net income attributable to noncontrolling interests included in continuing operations (18.7 ) (16.5 ) Less: Income allocated to participating securities (0.2 ) (0.3 ) Less: Convertible perpetual preferred stock dividends — (1.6 ) Income from continuing operations attributable to HealthSouth common shareholders 57.9 40.9 Loss from discontinued operations, net of tax, attributable to HealthSouth common shareholders (0.1 ) (0.3 ) Net income attributable to HealthSouth common shareholders $ 57.8 $ 40.6 Denominator: Basic weighted average common shares outstanding 89.5 87.1 Basic earnings per share attributable to HealthSouth common shareholders: Continuing operations $ 0.65 $ 0.47 Discontinued operations — — Net income $ 0.65 $ 0.47 Diluted: Numerator: Income from continuing operations $ 76.8 $ 59.3 Less: Net income attributable to noncontrolling interests included in continuing operations (18.7 ) (16.5 ) Add: Interest on convertible debt, net of tax 2.4 2.3 Income from continuing operations attributable to HealthSouth common shareholders 60.5 45.1 Loss from discontinued operations, net of tax, attributable to HealthSouth common shareholders (0.1 ) (0.3 ) Net income attributable to HealthSouth common shareholders $ 60.4 $ 44.8 Denominator: Diluted weighted average common shares outstanding 99.4 101.1 Diluted earnings per share attributable to HealthSouth common shareholders: Continuing operations $ 0.61 $ 0.44 Discontinued operations — — Net income $ 0.61 $ 0.44 The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions): Three Months Ended March 31, 2016 2015 Basic weighted average common shares outstanding 89.5 87.1 Convertible perpetual preferred stock — 3.2 Convertible senior subordinated notes 8.4 8.2 Restricted stock awards, dilutive stock options, restricted stock units, and common stock warrants 1.5 2.6 Diluted weighted average common shares outstanding 99.4 101.1 In October 2015 and February 2016, our board of directors declared cash dividends of $0.23 per share that were paid in January 2016 and April 2016, respectively. As of March 31, 2016 and December 31, 2015 , accrued common stock dividends of $21.2 million and $21.3 million , respectively, were included in Accrued expenses and other current liabilities in our condensed consolidated balance sheets. Future dividend payments are subject to declaration by our board of directors. The indenture underlying our convertible notes includes antidilutive protection that requires adjustments to the number of shares of common stock issuable upon conversion and the exercise price for common stock upon the occurrence of certain events, including payment of cash dividends on our common stock after a de minimis threshold. At issuance, the convertible notes had a conversion price of $39.65 per share, which was equal to an initial conversion rate of 25.2194 shares per $1,000 principal amount of the convertible notes. The payment of dividends on our common stock has triggered and will continue to trigger, from time to time, the antidilutive adjustment provisions of the convertible notes. The current conversion price of the conve rtible notes is $37.59 per share, and the conversion rate is 26.6011 for each $1,000 principal amount of the convertible notes. See Note 8, Long-term Debt , Note 10, Convertible Perpetual Preferred Stock , and Note 16, Earnings per Common Share , to the consolidated financial statements accompanying the 2015 Form 10-K for additional information related to our convertible notes, common stock, common stock warrants, and convertible perpetual preferred stock.

Contingencies and Other Commitm

Contingencies and Other Commitments	3 Months Ended
Contingencies and Other Commitments	Mar. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
Contingencies and Other Commitments	Contingencies and Other Commitments We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims, and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. The resolution of any such lawsuits, claims, or legal and regulatory proceedings could materially and adversely affect our financial position, results of operations, and cash flows in a given period. Other Litigation— We have been named as a defendant in a lawsuit filed March 28, 2003 by several individual stockholders in the Circuit Court of Jefferson County, Alabama, captioned Nichols v. HealthSouth Corp . The plaintiffs allege that we, some of our former officers, and our former investment bank engaged in a scheme to overstate and misrepresent our earnings and financial position. The plaintiffs are seeking compensatory and punitive damages. This case was stayed in the Circuit Court on August 8, 2005. The plaintiffs filed an amended complaint on November 9, 2010 to which we responded with a motion to dismiss filed on December 22, 2010. During a hearing on February 24, 2012, plaintiffs’ counsel indicated his intent to dismiss certain claims against us. Instead, on March 9, 2012, the plaintiffs amended their complaint to include additional securities fraud claims against HealthSouth and add several former officers to the lawsuit. On September 12, 2012, the plaintiffs further amended their complaint to request certification as a class action. One of those named officers has repeatedly attempted to remove the case to federal district court, most recently on December 11, 2012. We filed our latest motion to remand the case back to state court on January 10, 2013. On September 27, 2013, the federal court remanded the case back to state court. On November 25, 2014, the plaintiffs filed another amended complaint to assert new allegations relating to the time period of 1997 to 2002. On December 10, 2014, we filed a motion to dismiss on the grounds the plaintiffs lack standing because their claims are derivative in nature, and the claims are time-barred by the statute of limitations. The court has scheduled a hearing for May 19, 2016 to consider our motion to dismiss. We intend to vigorously defend ourselves in this case. Based on the stage of litigation, review of the current facts and circumstances as we understand them, the nature of the underlying claim, the results of the proceedings to date, and the nature and scope of the defense we continue to mount, we do not believe an adverse judgment or settlement is probable in this matter, and it is also not possible to estimate the amount of loss, if any, or range of possible loss that might result from an adverse judgment or settlement of this case. Governmental Inquiries and Investigations— On June 24, 2011, we received a document subpoena addressed to HealthSouth Hospital of Houston, a long-term acute care hospital (“LTCH”) we closed in August 2011, and issued from the Dallas, Texas office of the HHS-OIG. The subpoena stated it was in connection with an investigation of possible false or otherwise improper claims submitted to Medicare and Medicaid and requested documents and materials relating to patient admissions, length of stay, and discharge matters at this closed LTCH. We furnished the documents requested and have heard nothing from the HHS-OIG since December 2012. On March 4, 2013, we received document subpoenas from an office of the HHS-OIG addressed to four of our hospitals. Those subpoenas also requested complete copies of medical records for 100 patients treated at each of those hospitals between September 2008 and June 2012. The investigation is being conducted by the United States Department of Justice (the “DOJ”). On April 24, 2014, we received document subpoenas relating to an additional seven of our hospitals. The new subpoenas reference substantially similar investigation subject matter as the original subpoenas and request materials from the period January 2008 through December 2013. Two of the four hospitals addressed in the original set of subpoenas have received supplemental subpoenas to cover this new time period. The most recent subpoenas do not include requests for specific patient files. However, in February 2015, the DOJ requested the voluntary production of the medical records of an additional 70 patients, some of whom were treated in hospitals not subject to the subpoenas, and we provided these records. All of the subpoenas are in connection with an investigation of alleged improper or fraudulent claims submitted to Medicare and Medicaid and request documents and materials relating to practices, procedures, protocols and policies, of certain pre- and post-admissions activities at these hospitals including, among other things, marketing functions, pre-admission screening, post-admission physician evaluations, patient assessment instruments, individualized patient plans of care, and compliance with the Medicare 60% rule. Under the Medicare rule commonly referred to as the “ 60% rule,” an inpatient rehabilitation hospital must treat 60% or more of its patients from at least one of a specified list of medical conditions in order to be reimbursed at the inpatient rehabilitation hospital payment rates, rather than at the lower acute care hospital payment rates. We are cooperating fully with the DOJ in connection with these subpoenas and are currently unable to predict the timing or outcome of the related investigations. Other Matters— The False Claims Act, 18 U.S.C. § 287, allows private citizens, called “relators,” to institute civil proceedings alleging violations of the False Claims Act. These qui tam cases are generally sealed by the court at the time of filing. The only parties typically privy to the information contained in the complaint are the relator, the federal government, and the presiding court. It is possible that qui tam lawsuits have been filed against us and that those suits remain under seal or that we are unaware of such filings or prevented by existing law, court order, or agreement with the government from discussing or disclosing the filing of such suits. We may be subject to liability under one or more undisclosed qui tam cases brought pursuant to the False Claims Act. It is our obligation as a participant in Medicare and other federal healthcare programs to routinely conduct audits and reviews of the accuracy of our billing systems and other regulatory compliance matters. As a result of these reviews, we have made, and will continue to make, disclosures to the HHS-OIG and the United States Centers for Medicare and Medicaid Services relating to amounts we suspect represent over-payments from these programs, whether due to inaccurate billing or otherwise. Some of these disclosures have resulted in, or may result in, HealthSouth refunding amounts to Medicare or other federal healthcare programs.

Segment Reporting Segment Repor

Segment Reporting Segment Reporting	3 Months Ended
Segment Reporting Segment Reporting	Mar. 31, 2016
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	Segment Reporting Our internal financial reporting and management structure is focused on the major types of services provided by HealthSouth. We manage our operations using two operating segments which are also our reportable segments: (1) inpatient rehabilitation and (2) home health and hospice. These reportable operating segments are consistent with information used by our chief executive officer, who is our chief operating decision maker, to assess performance and allocate resources. The following is a brief description of our reportable segments: • Inpatient Rehabilitation - Our national network of inpatient rehabilitation hospitals stretches across 29 states and Puerto Rico, with a concentration of hospitals in the eastern half of the United States and Texas. As of March 31, 2016 , we operate 122 inpatient rehabilitation hospitals, including one hospital that operates as a joint venture which we account for using the equity method of accounting. In addition, we manage four inpatient rehabilitation units through management contracts. We provide specialized rehabilitative treatment on both an inpatient and outpatient basis. Our inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. • Home Health and Hospice - As of March 31, 2016 , we provide home health and hospice services in 213 locations across 24 states. Two of these agencies operate as joint ventures which we account for using the equity method of accounting. Our home health services include a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. We also provide specialized home care services in Texas and Kansas for pediatric patients with severe medical conditions. Our hospice services primarily include in-home services to terminally ill patients and their families to address patients’ physical needs, including pain control and symptom management, and to provide emotional and spiritual support. The accounting policies of our reportable segments are the same as those described in Note 1, Basis of Presentation , “Variable Interest Entities,” to these condensed consolidated financial statements and Note 1, Summary of Significant Accounting Policies , to the consolidated financial statements accompanying the 2015 Form 10-K. All revenues for our services are generated through external customers. See Note 1, Basis of Presentation , “Net Operating Revenues,” for the payor composition of our revenues. No corporate overhead is allocated to either of our reportable segments. Our chief operating decision maker evaluates the performance of our segments and allocates resources to them based on adjusted earnings before interest, taxes, depreciation, and amortization (“Segment Adjusted EBITDA”). Selected financial information for our reportable segments is as follows (in millions): Inpatient Rehabilitation Home Health and Hospice Three Months Ended March 31, Three Months Ended March 31, 2016 2015 2016 2015 Net operating revenues $ 749.2 $ 630.3 $ 160.6 $ 110.3 Less: Provision for doubtful accounts (15.6 ) (11.0 ) (0.9 ) (0.6 ) Net operating revenues less provision for doubtful accounts 733.6 619.3 159.7 109.7 Operating expenses: Inpatient rehabilitation: Salaries and benefits 369.9 306.4 — — Other operating expenses 104.8 95.2 — — Supplies 32.4 29.8 — — Occupancy costs 15.6 10.4 — — Home health and hospice: Cost of services sold (excluding depreciation and amortization) — — 78.4 53.4 Support and overhead costs — — 57.0 38.1 522.7 441.8 135.4 91.5 Other income (0.6 ) (0.5 ) — — Equity in net income of nonconsolidated affiliates (2.2 ) (1.6 ) (0.2 ) — Noncontrolling interests 16.8 15.2 1.9 1.3 Segment Adjusted EBITDA $ 196.9 $ 164.4 $ 22.6 $ 16.9 Capital expenditures $ 38.7 $ 26.3 $ 0.4 $ 0.3 Inpatient Rehabilitation Home Health and Hospice HealthSouth Consolidated As of March 31, 2016 Total assets $ 3,583.1 $ 1,096.5 $ 4,608.3 Investments in and advances to nonconsolidated affiliates 9.9 2.6 12.5 As of December 31, 2015 Total assets $ 3,589.0 $ 1,088.4 $ 4,606.1 Investments in and advances to nonconsolidated affiliates 9.3 2.4 11.7 Segment reconciliations (in millions): Three Months Ended March 31, 2016 2015 Total segment Adjusted EBITDA $ 219.5 $ 181.3 General and administrative expenses (31.9 ) (34.6 ) Depreciation and amortization (42.4 ) (31.9 ) (Loss) gain on disposal or impairment of assets (0.2 ) 1.5 Government, class action, and related settlements — (8.0 ) Professional fees - accounting, tax, and legal (0.2 ) (2.2 ) Loss on early extinguishment of debt (2.4 ) (1.2 ) Interest expense and amortization of debt discounts and fees (44.6 ) (31.8 ) Net income attributable to noncontrolling interests 18.7 16.5 Income from continuing operations before income tax expense $ 116.5 $ 89.6 March 31, 2016 December 31, 2015 Total assets for reportable segments $ 4,679.6 $ 4,677.4 Reclassification of deferred income tax liabilities to net deferred income tax assets (71.3 ) (71.3 ) Total consolidated assets $ 4,608.3 $ 4,606.1 Additional detail regarding the revenues of our operating segments by service line follows (in millions): Three Months Ended March 31, 2016 2015 Inpatient rehabilitation: Inpatient $ 719.4 $ 606.6 Outpatient and other 29.8 23.7 Total inpatient rehabilitation 749.2 630.3 Home health and hospice: Home health 150.9 103.9 Hospice 9.7 6.4 Total home health and hospice 160.6 110.3 Total net operating revenues $ 909.8 $ 740.6

Condensed Consolidating Financi

Condensed Consolidating Financial Information	3 Months Ended
Condensed Consolidating Financial Information	Mar. 31, 2016
Condensed Consolidating Financial Information [Abstract]
Condensed Consolidating Financial Information	Condensed Consolidating Financial Information The accompanying condensed consolidating financial information has been prepared and presented pursuant to SEC Regulation S-X, Rule 3-10, “Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered.” Each of the subsidiary guarantors is 100% owned by HealthSouth, and all guarantees are full and unconditional and joint and several, subject to certain customary conditions for release. HealthSouth’s investments in its consolidated subsidiaries, as well as guarantor subsidiaries’ investments in nonguarantor subsidiaries and nonguarantor subsidiaries’ investments in guarantor subsidiaries, are presented under the equity method of accounting with the related investment presented within the line items Intercompany receivable and investments in consolidated affiliates and Intercompany payable in the accompanying condensed consolidating balance sheets. The terms of our credit agreement allow us to declare and pay cash dividends on our common stock so long as: (1) we are not in default under our credit agreement and (2) our senior secured leverage ratio (as defined in our credit agreement) remains less than or equal to 1.75 x. The terms of our senior note indenture allow us to declare and pay cash dividends on our common stock so long as (1) we are not in default, (2) the consolidated coverage ratio (as defined in the indenture) exceeds 2 x or we are otherwise allowed under the indenture to incur debt, and (3) we have capacity under the indenture’s restricted payments covenant to declare and pay dividends. See Note 8, Long-term Debt , to the consolidated financial statements accompanying the 2015 Form 10-K. Periodically, certain wholly owned subsidiaries of HealthSouth make dividends or distributions of available cash and/or intercompany receivable balances to their parents. In addition, HealthSouth makes contributions to certain wholly owned subsidiaries. When made, these dividends, distributions, and contributions impact the Intercompany receivable , Intercompany payable , and HealthSouth shareholders’ equity line items in the accompanying condensed consolidating balance sheet but have no impact on the consolidated financial statements of HealthSouth Corporation. Three Months Ended March 31, 2016 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Net operating revenues $ 4.9 $ 550.7 $ 383.2 $ (29.0 ) $ 909.8 Less: Provision for doubtful accounts — (11.9 ) (4.6 ) — (16.5 ) Net operating revenues less provision for doubtful accounts 4.9 538.8 378.6 (29.0 ) 893.3 Operating expenses: Salaries and benefits 11.3 255.0 224.4 (4.6 ) 486.1 Other operating expenses 5.4 77.1 47.8 (11.1 ) 119.2 Occupancy costs 0.9 23.0 7.4 (13.3 ) 18.0 Supplies — 23.2 11.8 — 35.0 General and administrative expenses 33.2 — (1.3 ) — 31.9 Depreciation and amortization 2.4 25.7 14.3 — 42.4 Professional fees—accounting, tax, and legal 0.2 — — — 0.2 Total operating expenses 53.4 404.0 304.4 (29.0 ) 732.8 Loss on early extinguishment of debt 2.4 — — — 2.4 Interest expense and amortization of debt discounts and fees 38.9 5.2 5.3 (4.8 ) 44.6 Other income (4.7 ) (0.1 ) (0.6 ) 4.8 (0.6 ) Equity in net income of nonconsolidated affiliates — (2.1 ) (0.3 ) — (2.4 ) Equity in net income of consolidated affiliates (86.2 ) (8.2 ) — 94.4 — Management fees (34.2 ) 26.2 8.0 — — Income from continuing operations before income tax (benefit) expense 35.3 113.8 61.8 (94.4 ) 116.5 Provision for income tax (benefit) expense (22.8 ) 45.4 17.1 — 39.7 Income from continuing operations 58.1 68.4 44.7 (94.4 ) 76.8 Loss from discontinued operations, net of tax (0.1 ) — — — (0.1 ) Net income 58.0 68.4 44.7 (94.4 ) 76.7 Less: Net income attributable to noncontrolling interests — — (18.7 ) — (18.7 ) Net income attributable to HealthSouth $ 58.0 $ 68.4 $ 26.0 $ (94.4 ) $ 58.0 Comprehensive income $ 58.1 $ 68.4 $ 44.7 $ (94.4 ) $ 76.8 Comprehensive income attributable to HealthSouth $ 58.1 $ 68.4 $ 26.0 $ (94.4 ) $ 58.1 Three Months Ended March 31, 2015 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Net operating revenues $ 5.3 $ 456.8 $ 303.2 $ (24.7 ) $ 740.6 Less: Provision for doubtful accounts — (9.0 ) (2.6 ) — (11.6 ) Net operating revenues less provision for doubtful accounts 5.3 447.8 300.6 (24.7 ) 729.0 Operating expenses: Salaries and benefits 8.1 211.1 170.0 (4.1 ) 385.1 Other operating expenses 9.5 63.1 41.0 (10.4 ) 103.2 Occupancy costs 1.1 15.3 5.9 (10.2 ) 12.1 Supplies — 20.8 10.6 — 31.4 General and administrative expenses 34.3 — 0.3 — 34.6 Depreciation and amortization 2.3 19.1 10.5 — 31.9 Government, class action, and related settlements 8.0 — — — 8.0 Professional fees—accounting, tax, and legal 2.2 — — — 2.2 Total operating expenses 65.5 329.4 238.3 (24.7 ) 608.5 Loss on early extinguishment of debt 1.2 — — — 1.2 Interest expense and amortization of debt discounts and fees 29.2 2.3 2.7 (2.4 ) 31.8 Other income (2.3 ) — (0.6 ) 2.4 (0.5 ) Equity in net income of nonconsolidated affiliates — (1.6 ) — — (1.6 ) Equity in net income of consolidated affiliates (78.6 ) (8.1 ) — 86.7 — Management fees (28.5 ) 21.7 6.8 — — Income from continuing operations before income tax (benefit) expense 18.8 104.1 53.4 (86.7 ) 89.6 Provision for income tax (benefit) expense (24.0 ) 39.6 14.7 — 30.3 Income from continuing operations 42.8 64.5 38.7 (86.7 ) 59.3 Loss from discontinued operations, net of tax (0.3 ) — — — (0.3 ) Net income 42.5 64.5 38.7 (86.7 ) 59.0 Less: Net income attributable to noncontrolling interests — — (16.5 ) — (16.5 ) Net income attributable to HealthSouth $ 42.5 $ 64.5 $ 22.2 $ (86.7 ) $ 42.5 Comprehensive income $ 42.6 $ 64.5 $ 38.7 $ (86.7 ) $ 59.1 Comprehensive income attributable to HealthSouth $ 42.6 $ 64.5 $ 22.2 $ (86.7 ) $ 42.6 As of March 31, 2016 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Assets Current assets: Cash and cash equivalents $ 47.8 $ 2.7 $ 22.7 $ — $ 73.2 Accounts receivable, net — 277.7 154.2 — 431.9 Other current assets 59.1 21.6 127.5 (81.2 ) 127.0 Total current assets 106.9 302.0 304.4 (81.2 ) 632.1 Property and equipment, net 15.8 960.5 341.4 — 1,317.7 Goodwill — 863.2 1,028.7 — 1,891.9 Intangible assets, net 11.2 122.0 282.6 — 415.8 Deferred income tax assets 131.3 63.2 — (49.5 ) 145.0 Other long-term assets 48.2 81.0 76.6 — 205.8 Intercompany notes receivable 541.3 — — (541.3 ) — Intercompany receivable and investments in consolidated affiliates 2,802.0 — — (2,802.0 ) — Total assets $ 3,656.7 $ 2,391.9 $ 2,033.7 $ (3,474.0 ) $ 4,608.3 Liabilities and Shareholders’ Equity Current liabilities: Current portion of long-term debt $ 40.1 $ 6.6 $ 7.4 $ (17.5 ) $ 36.6 Accounts payable 6.0 38.2 18.5 — 62.7 Accrued expenses and other current liabilities 151.3 90.4 186.5 (63.7 ) 364.5 Total current liabilities 197.4 135.2 212.4 (81.2 ) 463.8 Long-term debt, net of current portion 2,769.7 254.0 55.9 — 3,079.6 Intercompany notes payable — — 541.3 (541.3 ) — Other long-term liabilities 40.1 14.3 139.6 (49.2 ) 144.8 Intercompany payable — 42.5 176.9 (219.4 ) — 3,007.2 446.0 1,126.1 (891.1 ) 3,688.2 Commitments and contingencies Redeemable noncontrolling interests — — 96.2 — 96.2 Shareholders’ equity: HealthSouth shareholders’ equity 649.5 1,945.9 637.0 (2,582.9 ) 649.5 Noncontrolling interests — — 174.4 — 174.4 Total shareholders’ equity 649.5 1,945.9 811.4 (2,582.9 ) 823.9 Total liabilities and shareholders’ equity $ 3,656.7 $ 2,391.9 $ 2,033.7 $ (3,474.0 ) $ 4,608.3 As of December 31, 2015 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Assets Current assets: Cash and cash equivalents $ 41.2 $ 1.3 $ 19.1 $ — $ 61.6 Accounts receivable, net — 267.2 143.3 — 410.5 Other current assets 29.3 22.7 93.4 (18.8 ) 126.6 Total current assets 70.5 291.2 255.8 (18.8 ) 598.7 Property and equipment, net 14.5 965.7 329.9 — 1,310.1 Goodwill — 863.2 1,026.9 — 1,890.1 Intangible assets, net 8.8 123.2 287.4 — 419.4 Deferred income tax assets 176.2 64.1 — (49.5 ) 190.8 Other long-term assets 48.6 75.3 73.1 — 197.0 Intercompany notes receivable 546.6 — — (546.6 ) — Intercompany receivable and investments in consolidated affiliates 2,779.7 — — (2,779.7 ) — Total assets $ 3,644.9 $ 2,382.7 $ 1,973.1 $ (3,394.6 ) $ 4,606.1 Liabilities and Shareholders’ Equity Current liabilities: Current portion of long-term debt $ 40.0 $ 6.8 $ 7.5 $ (17.5 ) $ 36.8 Accounts payable 5.8 35.2 20.6 — 61.6 Accrued expenses and other current liabilities 122.2 72.6 134.5 (1.3 ) 328.0 Total current liabilities 168.0 114.6 162.6 (18.8 ) 426.4 Long-term debt, net of current portion 2,821.9 255.6 57.2 — 3,134.7 Intercompany notes payable — — 546.6 (546.6 ) — Other long-term liabilities 43.6 12.4 137.7 (49.1 ) 144.6 Intercompany payable — 141.7 179.1 (320.8 ) — 3,033.5 524.3 1,083.2 (935.3 ) 3,705.7 Commitments and contingencies Redeemable noncontrolling interests — — 121.1 — 121.1 Shareholders’ equity: HealthSouth shareholders’ equity 611.4 1,858.4 600.9 (2,459.3 ) 611.4 Noncontrolling interests — — 167.9 — 167.9 Total shareholders’ equity 611.4 1,858.4 768.8 (2,459.3 ) 779.3 Total liabilities and shareholders’ equity $ 3,644.9 $ 2,382.7 $ 1,973.1 $ (3,394.6 ) $ 4,606.1 Three Months Ended March 31, 2016 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Net cash provided by operating activities $ 4.0 $ 93.4 $ 62.4 $ (0.1 ) $ 159.7 Cash flows from investing activities: Purchases of property and equipment (3.2 ) (13.4 ) (14.8 ) — (31.4 ) Capitalized software costs (7.7 ) — — — (7.7 ) Net change in restricted cash — — (3.2 ) — (3.2 ) Proceeds from repayment of intercompany notes receivable 5.0 — — (5.0 ) — Other — (0.3 ) 3.1 — 2.8 Net cash used in investing activities (5.9 ) (13.7 ) (14.9 ) (5.0 ) (39.5 ) Cash flows from financing activities: Principal payments on debt, including pre-payments (55.6 ) (0.4 ) (0.3 ) — (56.3 ) Principal payments on intercompany notes payable — — (5.0 ) 5.0 — Borrowings on revolving credit facility 60.0 — — — 60.0 Payments on revolving credit facility (60.0 ) — — — (60.0 ) Repurchases of common stock, including fees and expenses (12.9 ) — — — (12.9 ) Dividends paid on common stock (21.3 ) — — — (21.3 ) Distributions paid to noncontrolling interests of consolidated affiliates — — (15.6 ) — (15.6 ) Other 0.3 (1.4 ) (1.4 ) — (2.5 ) Change in intercompany advances 98.0 (76.5 ) (21.6 ) 0.1 — Net cash provided by (used in) financing activities 8.5 (78.3 ) (43.9 ) 5.1 (108.6 ) Increase in cash and cash equivalents 6.6 1.4 3.6 — 11.6 Cash and cash equivalents at beginning of period 41.2 1.3 19.1 — 61.6 Cash and cash equivalents at end of period $ 47.8 $ 2.7 $ 22.7 $ — $ 73.2 Three Months Ended March 31, 2015 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Net cash provided by operating activities $ 6.6 $ 53.0 $ 42.4 $ — $ 102.0 Cash flows from investing activities: Purchases of property and equipment (2.4 ) (8.2 ) (7.1 ) — (17.7 ) Capitalized software costs (8.8 ) — (0.1 ) — (8.9 ) Acquisitions of businesses, net of cash acquired — — (7.3 ) — (7.3 ) Net change in restricted cash — — (15.0 ) — (15.0 ) Other — 3.5 (0.3 ) — 3.2 Net cash used in investing activities (11.2 ) (4.7 ) (29.8 ) — (45.7 ) Cash flows from financing activities: Proceeds from bond issuance 700.0 — — — 700.0 Principal payments on debt, including pre-payments (252.5 ) (0.4 ) — — (252.9 ) Borrowings on revolving credit facility 35.0 — — — 35.0 Payments on revolving credit facility (350.0 ) — — — (350.0 ) Debt amendment and issuance costs (13.7 ) — — — (13.7 ) Dividends paid on common stock (18.6 ) — — — (18.6 ) Dividends paid on convertible perpetual preferred stock (1.6 ) — — — (1.6 ) Distributions paid to noncontrolling interests of consolidated affiliates — — (13.2 ) — (13.2 ) Other 1.7 (0.6 ) (0.8 ) — 0.3 Change in intercompany advances 52.0 (47.8 ) (4.2 ) — — Net cash provided by (used in) financing activities 152.3 (48.8 ) (18.2 ) — 85.3 Increase (decrease) in cash and cash equivalents 147.7 (0.5 ) (5.6 ) — 141.6 Cash and cash equivalents at beginning of period 41.9 1.5 23.3 — 66.7 Cash and cash equivalents at end of period $ 189.6 $ 1.0 $ 17.7 $ — $ 208.3

Basis of Presentation (Policies

Basis of Presentation (Policies)	3 Months Ended
Basis of Presentation (Policies)	Mar. 31, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Variable Interest Entities Policy	Variable Interest Entities — Effective January 1, 2016, in connection with our adoption of ASU 2015-02, we updated our evaluation of all jointly held legal entities to determine whether they are now variable interest entities (“VIEs”) under the new guidance. Any entity considered a VIE is evaluated to determine which party is the primary beneficiary and thus should consolidate the VIE. This analysis is complex, involves uncertainties, and requires significant judgment on various matters. In order to determine if we are the primary beneficiary of a VIE, we must determine what activities most significantly impact the economic performance of the entity, whether we have the power to direct those activities, and if our obligation to absorb losses or receive benefits from the VIE could potentially be significant to the VIE.
Net Operating Revenues Policy	Net Operating Revenues — We derived consolidated Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 75.4 % 74.9 % Medicare Advantage 7.8 % 8.2 % Managed care 9.5 % 10.0 % Medicaid 3.4 % 2.6 % Other third-party payors 1.4 % 1.5 % Workers’ compensation 0.9 % 0.9 % Patients 0.5 % 0.7 % Other income 1.1 % 1.2 % Total 100.0 % 100.0 % Inpatient Rehabilitation Revenues Our inpatient rehabilitation segment derived its Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 73.8 % 73.5 % Medicare Advantage 7.6 % 8.3 % Managed care 11.0 % 11.2 % Medicaid 3.0 % 2.0 % Other third-party payors 1.6 % 1.7 % Workers’ compensation 1.1 % 1.1 % Patients 0.6 % 0.8 % Other income 1.3 % 1.4 % Total 100.0 % 100.0 % Home Health and Hospice Revenues Our home health and hospice segment derived its Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 83.5 % 83.8 % Medicare Advantage 8.7 % 7.3 % Managed care 2.7 % 3.1 % Medicaid 4.9 % 5.6 % Other third-party payors — % 0.1 % Patients 0.1 % 0.1 % Other income 0.1 % — % Total 100.0 % 100.0 % See Note 1, Summary of Significant Accounting Policies , to the consolidated financial statements accompanying the 2015 Form 10-K for our policies related to Net operating revenues , Accounts receivable , and our Allowance for doubtful accounts.
Recent Accounting Pronouncements Policy	Recent Accounting Pronouncements — In February 2015, the FASB issued ASU 2015-02, “Consolidations (Topic 810) - Amendments to the Consolidation Analysis,” which provides guidance on evaluating whether a reporting entity should consolidate certain legal entities. Specifically, the amendments modify the evaluation of whether limited partnerships and similar legal entities are VIEs. Under this analysis, limited partnerships and other similar entities will be considered a VIE unless the limited partners hold substantive kick-out rights or participating rights. Further, the amendments eliminate the presumption that a general partner should consolidate a limited partnership under the voting interest model, as well as affect the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships. This standard was effective for annual periods beginning after December 15, 2015 and interim periods within those annual periods. We elected to adopt this guidance using the modified retrospective approach. Our adoption of this guidance resulted in certain limited partnership-like entities that were previously consolidated as voting interest entities to now be consolidated as VIEs, for which additional disclosures are required. Our adoption of ASU 2015-02 did not have a material impact on our financial position, results of operations, or cash flows. See Note 3 , Variable Interest Entities . In February 2016, the FASB issued ASU 2016-02, “Leases (Topic 842),” in order to increase transparency and comparability by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new standard, lessees will recognize a right-of-use asset and a corresponding lease liability for all leases other than leases that meet the definition of a short-term lease. The liability will be equal to the present value of lease payments. The asset will be based on the liability, subject to adjustment, such as for initial direct costs. For income statement purposes, the FASB retained a dual model, requiring leases to be classified as either operating or finance. Operating leases will result in straight-line expense while finance leases will result in an expense pattern similar to current capital leases. Classification will be based on criteria that are similar to those applied in current lease accounting. This standard will be effective for HealthSouth for the annual reporting period beginning after December 15, 2018. Early adoption is permitted. We continue to review the requirements of this standard and any potential impact it may have on our financial position, results of operations, or cash flows. In March 2016, the FASB issued ASU 2016-09, “Improvements to Employee Share-Based Payment Accounting (Topic 718),” to simplify various aspects of share-based payment accounting and presentation. The new standard requires entities to record all of the tax effects related to share-based payments at settlement (or expiration) through the income statement. This will require us to reclassify tax benefits in excess of compensation cost (“windfalls”) and tax deficiencies (“shortfalls”) to the extent of previous windfalls from Capital in excess of par value to Provision for income tax expense . This change is required to be applied prospectively to all excess tax benefits and tax deficiencies resulting from settlements after the date of adoption of the ASU. The standard eliminates the requirement to delay recognition of a windfall tax benefit until it reduces current taxes payable. This change is required to be applied on a modified retrospective basis, with a cumulative-effect adjustment to opening retained earnings. In addition, all income tax-related cash flows resulting from share-based payments are required to be reported as operating activities on the statement of cash flows as opposed to the current presentation as an inflow from financing activities and an outflow from operating activities. Either prospective or retrospective transition of this provision is permitted. Finally, the standard clarifies that all cash payments made to taxing authorities on the employees’ behalf for withheld shares should be presented as financing activities on the statement of cash flows. This change will be applied retrospectively. For public companies, this guidance is effective for annual reporting periods beginning after December 15, 2016 and interim periods within that reporting period. Early adoption is permitted, with any adjustments reflected as of the beginning of the fiscal year of adoption. We continue to review the requirements of this standard and any potential impact it may have on our financial position, results of operations, or cash flows.

Basis of Presentation (Tables)

Basis of Presentation (Tables)	3 Months Ended
Basis of Presentation (Tables)	Mar. 31, 2016
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Concentration of Net Operating Revenues by Payor	We derived consolidated Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 75.4 % 74.9 % Medicare Advantage 7.8 % 8.2 % Managed care 9.5 % 10.0 % Medicaid 3.4 % 2.6 % Other third-party payors 1.4 % 1.5 % Workers’ compensation 0.9 % 0.9 % Patients 0.5 % 0.7 % Other income 1.1 % 1.2 % Total 100.0 % 100.0 %
Inpatient Rehabilitation Hospital [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Concentration of Net Operating Revenues by Payor	Our inpatient rehabilitation segment derived its Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 73.8 % 73.5 % Medicare Advantage 7.6 % 8.3 % Managed care 11.0 % 11.2 % Medicaid 3.0 % 2.0 % Other third-party payors 1.6 % 1.7 % Workers’ compensation 1.1 % 1.1 % Patients 0.6 % 0.8 % Other income 1.3 % 1.4 % Total 100.0 % 100.0 %
Home Health and Hospice [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Concentration of Net Operating Revenues by Payor	Our home health and hospice segment derived its Net operating revenues from the following payor sources: Three Months Ended March 31, 2016 2015 Medicare 83.5 % 83.8 % Medicare Advantage 8.7 % 7.3 % Managed care 2.7 % 3.1 % Medicaid 4.9 % 5.6 % Other third-party payors — % 0.1 % Patients 0.1 % 0.1 % Other income 0.1 % — % Total 100.0 % 100.0 %

Business Combinations (Tables)

Business Combinations (Tables)	3 Months Ended
Business Combinations (Tables)	Mar. 31, 2016
Business Combinations [Abstract]
Schedule of Assets Acquired and Liabilities Assumed at the Acquisition Date	The fair value of the assets acquired at the acquisition date were as follows (in millions): Property and equipment $ 5.1 Identifiable intangible asset: Trade name (useful life of 20 years) 0.2 Goodwill 1.8 Total assets acquired $ 7.1
Schedule of Noncash or Part Noncash Acquisitions	Information regarding the net cash paid was as follows (in millions): Three Months Ended March 31, 2016 Fair value of assets acquired $ 5.3 Goodwill 1.8 Fair value of noncontrolling interest owned by joint venture partner (7.1 ) Net cash paid for acquisition $ —
Summary of Actual and Pro Forma Results of Operations for Acquisitions	The following table summarizes the results of operations of the above mentioned transaction from its respective date of acquisition included in our consolidated results of operations and the unaudited pro forma results of operations of the combined entity had the date of the acquisition been January 1, 2015 (in millions): Net Operating Revenues Net Income Attributable to HealthSouth Acquired entities only: Actual from acquisition date to March 31, 2016 $ 0.3 $ (0.7 ) Combined entity: Supplemental pro forma from 01/01/2016-03/31/2016 910.1 58.0 Combined entity: Supplemental pro forma from 01/01/2015-03/31/2015 741.6 42.6

Variable Interest Entities Va24

Variable Interest Entities Variable Interest Entities (Tables)	3 Months Ended
	Mar. 31, 2016
Variable Interest Entities [Abstract]
Schedule of carrying amounts and classifications of VIE's assets and liabilities	The carrying amounts and classifications of the consolidated VIEs’ assets and liabilities, which are included in our consolidated balance sheet, are as follows (in millions): March 31, 2016 Assets Current assets: Cash and cash equivalents $ 1.6 Accounts receivable, net of allowance for doubtful accounts 28.9 Other current assets 6.4 Total current assets 36.9 Property and equipment, net 126.8 Goodwill 73.5 Intangible assets, net 9.2 Other long-term assets 0.9 Total assets $ 247.3 Liabilities Current liabilities: Current portion of long-term debt $ 1.4 Accounts payable 7.5 Accrued expenses and other current liabilities 14.2 Total current liabilities 23.1 Long-term debt, net of current portion 30.9 Total liabilities $ 54.0

Investments in and Advances t25

Investments in and Advances to Nonconsolidated Affiliates (Tables)	3 Months Ended
	Mar. 31, 2016
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Abstract]
Schedule of Combined Results of Operations of Equity Method Affiliates	The following summarizes the combined results of operations of our equity method affiliates (on a 100% basis, in millions): Three Months Ended March 31, 2016 2015 Net operating revenues $ 11.2 $ 8.2 Operating expenses (3.2 ) (3.9 ) Income from continuing operations, net of tax 5.0 3.9 Net income 5.0 3.9

Long-term Debt (Tables)

Long-term Debt (Tables)	3 Months Ended
Long-term Debt (Tables)	Mar. 31, 2016
Debt Disclosure [Abstract]
Schedule of Outstanding Long-term Debt	Our long-term debt outstanding consists of the following (in millions): March 31, 2016 December 31, 2015 Credit Agreement— Advances under revolving credit facility $ 130.0 $ 130.0 Term loan facilities 437.8 443.3 Bonds payable— 7.75% Senior Notes due 2022 124.8 174.3 5.125% Senior Notes due 2023 294.8 294.6 5.75% Senior Notes due 2024 1,192.7 1,192.6 5.75% Senior Notes due 2025 343.5 343.4 2.00% Convertible Senior Subordinated Notes due 2043 268.3 265.9 Other notes payable 38.4 39.2 Capital lease obligations 285.9 288.2 3,116.2 3,171.5 Less: Current portion (36.6 ) (36.8 ) Long-term debt, net of current portion $ 3,079.6 $ 3,134.7
Schedule of Debt Maturities	The following chart shows scheduled principal payments due on long-term debt for the next five years and thereafter (in millions): Face Amount Net Amount April 1 through December 31, 2016 $ 27.8 $ 27.8 2017 36.5 36.5 2018 36.6 36.6 2019 39.6 39.6 2020 813.7 760.4 2021 10.1 10.1 Thereafter 2,225.4 2,205.2 Total $ 3,189.7 $ 3,116.2

Redeemable Noncontrolling Int27

Redeemable Noncontrolling Interests (Tables)	3 Months Ended
Redeemable Noncontrolling Interests (Tables)	Mar. 31, 2016
Redeemable Noncontrolling Interest [Line Items]
Redeemable Noncontrolling Interest	The following is a summary of the activity related to our Redeemable noncontrolling interests during the three months ended March 31, 2016 and 2015 (in millions): Three Months Ended March 31, 2016 2015 Balance at beginning of period $ 121.1 $ 84.7 Net income attributable to noncontrolling interests 3.9 2.9 Distributions declared (2.1 ) (1.7 ) Change in fair value (26.7 ) (1.2 ) Balance at end of period $ 96.2 $ 84.7
Reconciliation of Noncontrolling Interests	The following table reconciles the net income attributable to nonredeemable Noncontrolling interests , as recorded in the shareholders’ equity section of the condensed consolidated balance sheets, and the net income attributable to Redeemable noncontrolling interests , as recorded in the mezzanine section of the condensed consolidated balance sheets, to the Net income attributable to noncontrolling interests presented in the condensed consolidated statements of operations for the three months ended March 31, 2016 and 2015 (in millions): Three Months Ended March 31, 2016 2015 Net income attributable to nonredeemable noncontrolling interests $ 14.8 $ 13.6 Net income attributable to redeemable noncontrolling interests 3.9 2.9 Net income attributable to noncontrolling interests $ 18.7 $ 16.5

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
Fair Value Measurements (Tables)	Mar. 31, 2016
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on a Recurring Basis	Our financial assets and liabilities that are measured at fair value on a recurring basis are as follows (in millions): Fair Value Measurements at Reporting Date Using As of March 31, 2016 Fair Value Quoted Prices in Active Markets for Identical Assets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Valuation Technique (1) Other current assets: Current portion of restricted marketable securities $ 16.0 $ — $ 16.0 $ — M Other long-term assets: Restricted marketable securities 40.7 — 40.7 — M Redeemable noncontrolling interests 96.2 — — 96.2 I As of December 31, 2015 Other current assets: Current portion of restricted marketable securities $ 16.1 $ — $ 16.1 $ — M Other long-term assets: Restricted marketable securities 40.1 — 40.1 — M Redeemable noncontrolling interests 121.1 — — 121.1 I (1) The three valuation techniques are: market approach (M), cost approach (C), and income approach (I).
Schedule of Carrying Amounts and Estimated Fair Values, Financial Instruments	The carrying amounts and estimated fair values for all of our other financial instruments are presented in the following table (in millions): As of March 31, 2016 As of December 31, 2015 Carrying Amount Estimated Fair Value Carrying Amount Estimated Fair Value Long-term debt: Advances under revolving credit facility $ 130.0 $ 130.0 $ 130.0 $ 130.0 Term loan facilities 437.8 439.4 443.3 445.0 7.75% Senior Notes due 2022 124.8 131.5 174.3 183.7 5.125% Senior Notes due 2023 294.8 298.9 294.6 288.0 5.75% Senior Notes due 2024 1,192.7 1,218.0 1,192.6 1,146.0 5.75% Senior Notes due 2025 343.5 351.8 343.4 332.5 2.00% Convertible Senior Subordinated Notes due 2043 268.3 358.2 265.9 345.0 Other notes payable 38.4 38.4 39.2 39.2 Financial commitments: Letters of credit — 35.0 — 34.2

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
Income Taxes (Tables)	Mar. 31, 2016
Income Tax Disclosure [Abstract]
Summary of Income Tax Contingencies	A reconciliation of the beginning and ending liability for unrecognized tax benefits is as follows (in millions): Gross Unrecognized Income Tax Benefits Balance at December 31, 2015 $ 2.9 Gross amount of increases in unrecognized tax benefits related to current periods 0.1 Balance at March 31, 2016 $ 3.0

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	3 Months Ended
Earnings per Common Share (Tables)	Mar. 31, 2016
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Common Share	The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts): Three Months Ended March 31, 2016 2015 Basic: Numerator: Income from continuing operations $ 76.8 $ 59.3 Less: Net income attributable to noncontrolling interests included in continuing operations (18.7 ) (16.5 ) Less: Income allocated to participating securities (0.2 ) (0.3 ) Less: Convertible perpetual preferred stock dividends — (1.6 ) Income from continuing operations attributable to HealthSouth common shareholders 57.9 40.9 Loss from discontinued operations, net of tax, attributable to HealthSouth common shareholders (0.1 ) (0.3 ) Net income attributable to HealthSouth common shareholders $ 57.8 $ 40.6 Denominator: Basic weighted average common shares outstanding 89.5 87.1 Basic earnings per share attributable to HealthSouth common shareholders: Continuing operations $ 0.65 $ 0.47 Discontinued operations — — Net income $ 0.65 $ 0.47 Diluted: Numerator: Income from continuing operations $ 76.8 $ 59.3 Less: Net income attributable to noncontrolling interests included in continuing operations (18.7 ) (16.5 ) Add: Interest on convertible debt, net of tax 2.4 2.3 Income from continuing operations attributable to HealthSouth common shareholders 60.5 45.1 Loss from discontinued operations, net of tax, attributable to HealthSouth common shareholders (0.1 ) (0.3 ) Net income attributable to HealthSouth common shareholders $ 60.4 $ 44.8 Denominator: Diluted weighted average common shares outstanding 99.4 101.1 Diluted earnings per share attributable to HealthSouth common shareholders: Continuing operations $ 0.61 $ 0.44 Discontinued operations — — Net income $ 0.61 $ 0.44
Reconciliation of Weighted Average Number of Shares Outstanding	The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions): Three Months Ended March 31, 2016 2015 Basic weighted average common shares outstanding 89.5 87.1 Convertible perpetual preferred stock — 3.2 Convertible senior subordinated notes 8.4 8.2 Restricted stock awards, dilutive stock options, restricted stock units, and common stock warrants 1.5 2.6 Diluted weighted average common shares outstanding 99.4 101.1

Segment Reporting Segment Rep31

Segment Reporting Segment Reporting (Tables)	3 Months Ended
Segment Reporting Segment Reporting (Tables)	Mar. 31, 2016
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Selected financial information for our reportable segments is as follows (in millions): Inpatient Rehabilitation Home Health and Hospice Three Months Ended March 31, Three Months Ended March 31, 2016 2015 2016 2015 Net operating revenues $ 749.2 $ 630.3 $ 160.6 $ 110.3 Less: Provision for doubtful accounts (15.6 ) (11.0 ) (0.9 ) (0.6 ) Net operating revenues less provision for doubtful accounts 733.6 619.3 159.7 109.7 Operating expenses: Inpatient rehabilitation: Salaries and benefits 369.9 306.4 — — Other operating expenses 104.8 95.2 — — Supplies 32.4 29.8 — — Occupancy costs 15.6 10.4 — — Home health and hospice: Cost of services sold (excluding depreciation and amortization) — — 78.4 53.4 Support and overhead costs — — 57.0 38.1 522.7 441.8 135.4 91.5 Other income (0.6 ) (0.5 ) — — Equity in net income of nonconsolidated affiliates (2.2 ) (1.6 ) (0.2 ) — Noncontrolling interests 16.8 15.2 1.9 1.3 Segment Adjusted EBITDA $ 196.9 $ 164.4 $ 22.6 $ 16.9 Capital expenditures $ 38.7 $ 26.3 $ 0.4 $ 0.3
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	Inpatient Rehabilitation Home Health and Hospice HealthSouth Consolidated As of March 31, 2016 Total assets $ 3,583.1 $ 1,096.5 $ 4,608.3 Investments in and advances to nonconsolidated affiliates 9.9 2.6 12.5 As of December 31, 2015 Total assets $ 3,589.0 $ 1,088.4 $ 4,606.1 Investments in and advances to nonconsolidated affiliates 9.3 2.4 11.7 March 31, 2016 December 31, 2015 Total assets for reportable segments $ 4,679.6 $ 4,677.4 Reclassification of deferred income tax liabilities to net deferred income tax assets (71.3 ) (71.3 ) Total consolidated assets $ 4,608.3 $ 4,606.1
Reconciliation of Segment Adjusted EBITDA to Income from Continuing Operations Before Income Tax Expense [Table Text Block]	Segment reconciliations (in millions): Three Months Ended March 31, 2016 2015 Total segment Adjusted EBITDA $ 219.5 $ 181.3 General and administrative expenses (31.9 ) (34.6 ) Depreciation and amortization (42.4 ) (31.9 ) (Loss) gain on disposal or impairment of assets (0.2 ) 1.5 Government, class action, and related settlements — (8.0 ) Professional fees - accounting, tax, and legal (0.2 ) (2.2 ) Loss on early extinguishment of debt (2.4 ) (1.2 ) Interest expense and amortization of debt discounts and fees (44.6 ) (31.8 ) Net income attributable to noncontrolling interests 18.7 16.5 Income from continuing operations before income tax expense $ 116.5 $ 89.6
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]	Additional detail regarding the revenues of our operating segments by service line follows (in millions): Three Months Ended March 31, 2016 2015 Inpatient rehabilitation: Inpatient $ 719.4 $ 606.6 Outpatient and other 29.8 23.7 Total inpatient rehabilitation 749.2 630.3 Home health and hospice: Home health 150.9 103.9 Hospice 9.7 6.4 Total home health and hospice 160.6 110.3 Total net operating revenues $ 909.8 $ 740.6

Condensed Consolidating Finan32

Condensed Consolidating Financial Information (Tables)	3 Months Ended
Condensed Consolidating Financial Information (Tables)	Mar. 31, 2016
Condensed Consolidating Financial Information [Abstract]
Condensed Consolidating Statement of Operations	Three Months Ended March 31, 2016 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Net operating revenues $ 4.9 $ 550.7 $ 383.2 $ (29.0 ) $ 909.8 Less: Provision for doubtful accounts — (11.9 ) (4.6 ) — (16.5 ) Net operating revenues less provision for doubtful accounts 4.9 538.8 378.6 (29.0 ) 893.3 Operating expenses: Salaries and benefits 11.3 255.0 224.4 (4.6 ) 486.1 Other operating expenses 5.4 77.1 47.8 (11.1 ) 119.2 Occupancy costs 0.9 23.0 7.4 (13.3 ) 18.0 Supplies — 23.2 11.8 — 35.0 General and administrative expenses 33.2 — (1.3 ) — 31.9 Depreciation and amortization 2.4 25.7 14.3 — 42.4 Professional fees—accounting, tax, and legal 0.2 — — — 0.2 Total operating expenses 53.4 404.0 304.4 (29.0 ) 732.8 Loss on early extinguishment of debt 2.4 — — — 2.4 Interest expense and amortization of debt discounts and fees 38.9 5.2 5.3 (4.8 ) 44.6 Other income (4.7 ) (0.1 ) (0.6 ) 4.8 (0.6 ) Equity in net income of nonconsolidated affiliates — (2.1 ) (0.3 ) — (2.4 ) Equity in net income of consolidated affiliates (86.2 ) (8.2 ) — 94.4 — Management fees (34.2 ) 26.2 8.0 — — Income from continuing operations before income tax (benefit) expense 35.3 113.8 61.8 (94.4 ) 116.5 Provision for income tax (benefit) expense (22.8 ) 45.4 17.1 — 39.7 Income from continuing operations 58.1 68.4 44.7 (94.4 ) 76.8 Loss from discontinued operations, net of tax (0.1 ) — — — (0.1 ) Net income 58.0 68.4 44.7 (94.4 ) 76.7 Less: Net income attributable to noncontrolling interests — — (18.7 ) — (18.7 ) Net income attributable to HealthSouth $ 58.0 $ 68.4 $ 26.0 $ (94.4 ) $ 58.0 Comprehensive income $ 58.1 $ 68.4 $ 44.7 $ (94.4 ) $ 76.8 Comprehensive income attributable to HealthSouth $ 58.1 $ 68.4 $ 26.0 $ (94.4 ) $ 58.1 Three Months Ended March 31, 2015 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Net operating revenues $ 5.3 $ 456.8 $ 303.2 $ (24.7 ) $ 740.6 Less: Provision for doubtful accounts — (9.0 ) (2.6 ) — (11.6 ) Net operating revenues less provision for doubtful accounts 5.3 447.8 300.6 (24.7 ) 729.0 Operating expenses: Salaries and benefits 8.1 211.1 170.0 (4.1 ) 385.1 Other operating expenses 9.5 63.1 41.0 (10.4 ) 103.2 Occupancy costs 1.1 15.3 5.9 (10.2 ) 12.1 Supplies — 20.8 10.6 — 31.4 General and administrative expenses 34.3 — 0.3 — 34.6 Depreciation and amortization 2.3 19.1 10.5 — 31.9 Government, class action, and related settlements 8.0 — — — 8.0 Professional fees—accounting, tax, and legal 2.2 — — — 2.2 Total operating expenses 65.5 329.4 238.3 (24.7 ) 608.5 Loss on early extinguishment of debt 1.2 — — — 1.2 Interest expense and amortization of debt discounts and fees 29.2 2.3 2.7 (2.4 ) 31.8 Other income (2.3 ) — (0.6 ) 2.4 (0.5 ) Equity in net income of nonconsolidated affiliates — (1.6 ) — — (1.6 ) Equity in net income of consolidated affiliates (78.6 ) (8.1 ) — 86.7 — Management fees (28.5 ) 21.7 6.8 — — Income from continuing operations before income tax (benefit) expense 18.8 104.1 53.4 (86.7 ) 89.6 Provision for income tax (benefit) expense (24.0 ) 39.6 14.7 — 30.3 Income from continuing operations 42.8 64.5 38.7 (86.7 ) 59.3 Loss from discontinued operations, net of tax (0.3 ) — — — (0.3 ) Net income 42.5 64.5 38.7 (86.7 ) 59.0 Less: Net income attributable to noncontrolling interests — — (16.5 ) — (16.5 ) Net income attributable to HealthSouth $ 42.5 $ 64.5 $ 22.2 $ (86.7 ) $ 42.5 Comprehensive income $ 42.6 $ 64.5 $ 38.7 $ (86.7 ) $ 59.1 Comprehensive income attributable to HealthSouth $ 42.6 $ 64.5 $ 22.2 $ (86.7 ) $ 42.6
Condensed Consolidating Balance Sheet	As of March 31, 2016 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Assets Current assets: Cash and cash equivalents $ 47.8 $ 2.7 $ 22.7 $ — $ 73.2 Accounts receivable, net — 277.7 154.2 — 431.9 Other current assets 59.1 21.6 127.5 (81.2 ) 127.0 Total current assets 106.9 302.0 304.4 (81.2 ) 632.1 Property and equipment, net 15.8 960.5 341.4 — 1,317.7 Goodwill — 863.2 1,028.7 — 1,891.9 Intangible assets, net 11.2 122.0 282.6 — 415.8 Deferred income tax assets 131.3 63.2 — (49.5 ) 145.0 Other long-term assets 48.2 81.0 76.6 — 205.8 Intercompany notes receivable 541.3 — — (541.3 ) — Intercompany receivable and investments in consolidated affiliates 2,802.0 — — (2,802.0 ) — Total assets $ 3,656.7 $ 2,391.9 $ 2,033.7 $ (3,474.0 ) $ 4,608.3 Liabilities and Shareholders’ Equity Current liabilities: Current portion of long-term debt $ 40.1 $ 6.6 $ 7.4 $ (17.5 ) $ 36.6 Accounts payable 6.0 38.2 18.5 — 62.7 Accrued expenses and other current liabilities 151.3 90.4 186.5 (63.7 ) 364.5 Total current liabilities 197.4 135.2 212.4 (81.2 ) 463.8 Long-term debt, net of current portion 2,769.7 254.0 55.9 — 3,079.6 Intercompany notes payable — — 541.3 (541.3 ) — Other long-term liabilities 40.1 14.3 139.6 (49.2 ) 144.8 Intercompany payable — 42.5 176.9 (219.4 ) — 3,007.2 446.0 1,126.1 (891.1 ) 3,688.2 Commitments and contingencies Redeemable noncontrolling interests — — 96.2 — 96.2 Shareholders’ equity: HealthSouth shareholders’ equity 649.5 1,945.9 637.0 (2,582.9 ) 649.5 Noncontrolling interests — — 174.4 — 174.4 Total shareholders’ equity 649.5 1,945.9 811.4 (2,582.9 ) 823.9 Total liabilities and shareholders’ equity $ 3,656.7 $ 2,391.9 $ 2,033.7 $ (3,474.0 ) $ 4,608.3 As of December 31, 2015 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Assets Current assets: Cash and cash equivalents $ 41.2 $ 1.3 $ 19.1 $ — $ 61.6 Accounts receivable, net — 267.2 143.3 — 410.5 Other current assets 29.3 22.7 93.4 (18.8 ) 126.6 Total current assets 70.5 291.2 255.8 (18.8 ) 598.7 Property and equipment, net 14.5 965.7 329.9 — 1,310.1 Goodwill — 863.2 1,026.9 — 1,890.1 Intangible assets, net 8.8 123.2 287.4 — 419.4 Deferred income tax assets 176.2 64.1 — (49.5 ) 190.8 Other long-term assets 48.6 75.3 73.1 — 197.0 Intercompany notes receivable 546.6 — — (546.6 ) — Intercompany receivable and investments in consolidated affiliates 2,779.7 — — (2,779.7 ) — Total assets $ 3,644.9 $ 2,382.7 $ 1,973.1 $ (3,394.6 ) $ 4,606.1 Liabilities and Shareholders’ Equity Current liabilities: Current portion of long-term debt $ 40.0 $ 6.8 $ 7.5 $ (17.5 ) $ 36.8 Accounts payable 5.8 35.2 20.6 — 61.6 Accrued expenses and other current liabilities 122.2 72.6 134.5 (1.3 ) 328.0 Total current liabilities 168.0 114.6 162.6 (18.8 ) 426.4 Long-term debt, net of current portion 2,821.9 255.6 57.2 — 3,134.7 Intercompany notes payable — — 546.6 (546.6 ) — Other long-term liabilities 43.6 12.4 137.7 (49.1 ) 144.6 Intercompany payable — 141.7 179.1 (320.8 ) — 3,033.5 524.3 1,083.2 (935.3 ) 3,705.7 Commitments and contingencies Redeemable noncontrolling interests — — 121.1 — 121.1 Shareholders’ equity: HealthSouth shareholders’ equity 611.4 1,858.4 600.9 (2,459.3 ) 611.4 Noncontrolling interests — — 167.9 — 167.9 Total shareholders’ equity 611.4 1,858.4 768.8 (2,459.3 ) 779.3 Total liabilities and shareholders’ equity $ 3,644.9 $ 2,382.7 $ 1,973.1 $ (3,394.6 ) $ 4,606.1
Condensed Consolidating Statement of Cash Flows	Three Months Ended March 31, 2016 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Net cash provided by operating activities $ 4.0 $ 93.4 $ 62.4 $ (0.1 ) $ 159.7 Cash flows from investing activities: Purchases of property and equipment (3.2 ) (13.4 ) (14.8 ) — (31.4 ) Capitalized software costs (7.7 ) — — — (7.7 ) Net change in restricted cash — — (3.2 ) — (3.2 ) Proceeds from repayment of intercompany notes receivable 5.0 — — (5.0 ) — Other — (0.3 ) 3.1 — 2.8 Net cash used in investing activities (5.9 ) (13.7 ) (14.9 ) (5.0 ) (39.5 ) Cash flows from financing activities: Principal payments on debt, including pre-payments (55.6 ) (0.4 ) (0.3 ) — (56.3 ) Principal payments on intercompany notes payable — — (5.0 ) 5.0 — Borrowings on revolving credit facility 60.0 — — — 60.0 Payments on revolving credit facility (60.0 ) — — — (60.0 ) Repurchases of common stock, including fees and expenses (12.9 ) — — — (12.9 ) Dividends paid on common stock (21.3 ) — — — (21.3 ) Distributions paid to noncontrolling interests of consolidated affiliates — — (15.6 ) — (15.6 ) Other 0.3 (1.4 ) (1.4 ) — (2.5 ) Change in intercompany advances 98.0 (76.5 ) (21.6 ) 0.1 — Net cash provided by (used in) financing activities 8.5 (78.3 ) (43.9 ) 5.1 (108.6 ) Increase in cash and cash equivalents 6.6 1.4 3.6 — 11.6 Cash and cash equivalents at beginning of period 41.2 1.3 19.1 — 61.6 Cash and cash equivalents at end of period $ 47.8 $ 2.7 $ 22.7 $ — $ 73.2 Three Months Ended March 31, 2015 HealthSouth Corporation Guarantor Subsidiaries Nonguarantor Subsidiaries Eliminating Entries HealthSouth Consolidated (In Millions) Net cash provided by operating activities $ 6.6 $ 53.0 $ 42.4 $ — $ 102.0 Cash flows from investing activities: Purchases of property and equipment (2.4 ) (8.2 ) (7.1 ) — (17.7 ) Capitalized software costs (8.8 ) — (0.1 ) — (8.9 ) Acquisitions of businesses, net of cash acquired — — (7.3 ) — (7.3 ) Net change in restricted cash — — (15.0 ) — (15.0 ) Other — 3.5 (0.3 ) — 3.2 Net cash used in investing activities (11.2 ) (4.7 ) (29.8 ) — (45.7 ) Cash flows from financing activities: Proceeds from bond issuance 700.0 — — — 700.0 Principal payments on debt, including pre-payments (252.5 ) (0.4 ) — — (252.9 ) Borrowings on revolving credit facility 35.0 — — — 35.0 Payments on revolving credit facility (350.0 ) — — — (350.0 ) Debt amendment and issuance costs (13.7 ) — — — (13.7 ) Dividends paid on common stock (18.6 ) — — — (18.6 ) Dividends paid on convertible perpetual preferred stock (1.6 ) — — — (1.6 ) Distributions paid to noncontrolling interests of consolidated affiliates — — (13.2 ) — (13.2 ) Other 1.7 (0.6 ) (0.8 ) — 0.3 Change in intercompany advances 52.0 (47.8 ) (4.2 ) — — Net cash provided by (used in) financing activities 152.3 (48.8 ) (18.2 ) — 85.3 Increase (decrease) in cash and cash equivalents 147.7 (0.5 ) (5.6 ) — 141.6 Cash and cash equivalents at beginning of period 41.9 1.5 23.3 — 66.7 Cash and cash equivalents at end of period $ 189.6 $ 1.0 $ 17.7 $ — $ 208.3

Basis of Presentation - Table 1

Basis of Presentation - Table 1 (Details)	3 Months Ended
Basis of Presentation - Table 1 (Details)	Mar. 31, 2016	Mar. 31, 2015
Basis of Presentation [Abstract]
Medicare	75.40%	74.90%
Medicare Advantage	7.80%	8.20%
Managed care	9.50%	10.00%
Medicaid	3.40%	2.60%
Other third-party payors	1.40%	1.50%
Workers’ compensation	0.90%	0.90%
Patients	0.50%	0.70%
Other income	1.10%	1.20%
Total	100.00%	100.00%

Basis of Presentation Basis of

Basis of Presentation Basis of Presentation - Table 2 (Details)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Medicare	75.40%	74.90%
Medicare Advantage	7.80%	8.20%
Managed care	9.50%	10.00%
Medicaid	3.40%	2.60%
Other third-party payors	1.40%	1.50%
Workers’ compensation	0.90%	0.90%
Patients	0.50%	0.70%
Other income	1.10%	1.20%
Total	100.00%	100.00%
Inpatient Rehabilitation Hospital [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Medicare	73.80%	73.50%
Medicare Advantage	7.60%	8.30%
Managed care	11.00%	11.20%
Medicaid	3.00%	2.00%
Other third-party payors	1.60%	1.70%
Workers’ compensation	1.10%	1.10%
Patients	0.60%	0.80%
Other income	1.30%	1.40%
Total	100.00%	100.00%

Basis of Presentation Basis o35

Basis of Presentation Basis of Presentation - Table 3 (Details)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Medicare	75.40%	74.90%
Medicare Advantage	7.80%	8.20%
Managed care	9.50%	10.00%
Medicaid	3.40%	2.60%
Other third-party payors	1.40%	1.50%
Patients	0.50%	0.70%
Other income	1.10%	1.20%
Total	100.00%	100.00%
Home Health and Hospice [Member]
Health Care Organization, Receivable and Revenue Disclosures [Line Items]
Medicare	83.50%	83.80%
Medicare Advantage	8.70%	7.30%
Managed care	2.70%	3.10%
Medicaid	4.90%	5.60%
Other third-party payors	0.00%	0.10%
Patients	0.10%	0.10%
Other income	0.10%	0.00%
Total	100.00%	100.00%

Business Combinations - Table 1

Business Combinations - Table 1 (Details) - USD ($) $ in Millions	Mar. 31, 2016	Feb. 01, 2016	Dec. 31, 2015
Business Acquisition [Line Items]
Goodwill	$ 1,891.9		$ 1,890.1
Inpatient Rehabilitation Hospital [Member]
Business Acquisition [Line Items]
Property and equipment		$ 5.1
Goodwill		1.8
Total assets acquired		7.1
Inpatient Rehabilitation Hospital [Member] \| Trade Names [Member]
Business Acquisition [Line Items]
Identifiable intangible assets		$ 0.2

Business Combinations - Table 2

Business Combinations - Table 2 (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended
	Feb. 29, 2016	Mar. 31, 2016	Mar. 31, 2015
Net Cash Paid For All Acquisitions During Each Period Presented
Net cash paid for acquisition		$ 0	$ 7.3
Inpatient Rehabilitation Hospital [Member]
Net Cash Paid For All Acquisitions During Each Period Presented
Fair value of assets acquired		5.3
Goodwill	$ 1.8	1.8
Fair value of noncontrolling interests owned by joint venture partner		(7.1)
Net cash paid for acquisition		$ 0

Business Combinations - Table 3

Business Combinations - Table 3 (Details) - USD ($) $ in Millions	2 Months Ended	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2016	Mar. 31, 2015
Summary of Actual and Pro Forma Results of Operations for Acquisitions
Acquired entity only: Actual from acquisition date to March 31, 2016, Net Operating Revenues	$ 0.3
Acquired entities only: Actual from acquisition date to March 31, 2016, Net Income Attributable to HealthSouth	$ (0.7)
Combined entity: Supplemental pro forma, Net Operating Revenues		$ 910.1	$ 741.6
Combined entity: Supplemental pro forma, Net Income Attributable to HealthSouth		$ 58	$ 42.6

Business Combinations - Textual

Business Combinations - Textual (Details) - Inpatient Rehabilitation Hospital [Member] $ in Millions	1 Months Ended	3 Months Ended
	Feb. 29, 2016USD ($)	Mar. 31, 2016USD ($)	Feb. 01, 2016USD ($)
Business Acquisition (Textual) [Abstract]
Number of Beds Acquired			20
Noncontrolling Interest, Ownership Percentage by Parent			50.00%
Goodwill, Acquired During Period	$ 1.8	$ 1.8
Business Acquisition, Goodwill, Expected Tax Deductible Amount			$ 0
Trade Names [Member]
Business Acquisition [Line Items]
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		20 years

Variable Interest Entities Va40

Variable Interest Entities Variable Interest Entities - Table 1 (Details) - USD ($) $ in Millions	Mar. 31, 2016		Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014
Variable Interest Entity [Line Items]
Cash and cash equivalents	$ 73.2		$ 61.6	$ 208.3	$ 66.7
Accounts receivable, net	431.9		410.5
Other current assets	127		126.6
Total current assets	632.1		598.7
Property and equipment, net	1,317.7		1,310.1
Goodwill	1,891.9		1,890.1
Intangible assets, net	415.8		419.4
Other long-term assets	205.8		197
Total assets	4,608.3	[1]	4,606.1
Current portion of long-term debt	36.6		36.8
Accounts payable	62.7		61.6
Accrued expenses and other current liabilities	364.5		328
Total current liabilities	463.8		426.4
Long-term debt, net of current portion	3,079.6		3,134.7
Total Liabilities	3,688.2		$ 3,705.7
Variable Interest Entity, Primary Beneficiary, Aggregated Disclosure [Member]
Variable Interest Entity [Line Items]
Cash and cash equivalents	1.6
Accounts receivable, net	28.9
Other current assets	6.4
Total current assets	36.9
Property and equipment, net	126.8
Goodwill	73.5
Intangible assets, net	9.2
Other long-term assets	0.9
Total assets	247.3
Current portion of long-term debt	1.4
Accounts payable	7.5
Accrued expenses and other current liabilities	14.2
Total current liabilities	23.1
Long-term debt, net of current portion	30.9
Total Liabilities	$ 54

[1]	(1) Our consolidated assets as of March 31, 2016 include total assets of variable interest entities of $247.3 million, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of March 31, 2016 include total liabilities of the variable interest entities of $54.0 million. See Note 3, Variable Interest Entities.

Variable Interest Entities Va41

Variable Interest Entities Variable Interest Entities - Textual (Details)	3 Months Ended
	Mar. 31, 2016facilities
Variable Interest Entity [Line Items]
Number of Facilities Consolidated As Variable Interest Entities	10
Minimum [Member]
Variable Interest Entity [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	6.80%
Maximum [Member]
Variable Interest Entity [Line Items]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	99.50%

Investments In and Advances t42

Investments In and Advances to Nonconsolidated Affiliates - Table 1 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Equity Method Investment, Summarized Financial Information, Income Statement [Abstract]
Net operating revenues	$ 11.2	$ 8.2
Operating expenses	(3.2)	(3.9)
Income from continuing operations, net of tax	5	3.9
Net income	$ 5	$ 3.9

Investments in and Advances t43

Investments in and Advances to Nonconsolidated Affiliates - Textual (Details) $ in Millions	Mar. 31, 2016USD ($)facilities	Dec. 31, 2015USD ($)
Investments In and Advances to Nonconsolidated Affiliates (Textual) [Abstract]
Investments In and Advances To Nonconsolidated Affiliates \| $	$ 12.5	$ 11.7
Number of Partially Owned Subsidiaries, Nonconsolidated	7
Number of General or Limited Partnerships, Limited Liability Companies, or Joint Ventures, Nonconsolidated	6
Minimum [Member]
Investments In and Advances to Nonconsolidated Affiliates (Textual) [Abstract]
Nonconsolidated Affiliates, Ownership Percentage	1.00%
Maximum [Member]
Investments In and Advances to Nonconsolidated Affiliates (Textual) [Abstract]
Nonconsolidated Affiliates, Ownership Percentage	60.00%

Long-term Debt - Table 1 (Detai

Long-term Debt - Table 1 (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Schedule of Outstanding Long-term Debt
Advances under revolving credit facility	$ 130	$ 130
Other notes payable	38.4	39.2
Capital lease obligations	285.9	288.2
Total debt and capital lease obligations	3,116.2	3,171.5
Less: Current portion	(36.6)	(36.8)
Long-term debt, net of current portion	3,079.6	3,134.7
Term Loan Facilities [Member]
Schedule of Outstanding Long-term Debt
Term loan facilities	437.8	443.3
7.75% Senior Notes Due 2022 [Member]
Schedule of Outstanding Long-term Debt
Senior Notes	124.8	174.3
5.125% Senior Notes Due 2023 [Member]
Schedule of Outstanding Long-term Debt
Senior Notes	294.8	294.6
5.75% Senior Notes Due 2024 [Member]
Schedule of Outstanding Long-term Debt
Senior Notes	1,192.7	1,192.6
5.75% Senior Notes Due 2025 [Member]
Schedule of Outstanding Long-term Debt
Senior Notes	343.5	343.4
2.00% Convertible Senior Subordinated Notes due 2043 [Member]
Schedule of Outstanding Long-term Debt
Convertible Subordinated Debt	$ 268.3	$ 265.9

Long-term Debt - Table 2 (Detai

Long-term Debt - Table 2 (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Long-term Debt by Maturity
Total debt and capital lease obligations	$ 3,116.2	$ 3,171.5
Face Amount [Member]
Long-term Debt by Maturity
April 1 through December 31, 2016	27.8
2,017	36.5
2,018	36.6
2,019	39.6
2,020	813.7
2,021	10.1
Thereafter	2,225.4
Total debt and capital lease obligations	3,189.7
Net Amount [Member]
Long-term Debt by Maturity
April 1 through December 31, 2016	27.8
2,017	36.5
2,018	36.6
2,019	39.6
2,020	760.4
2,021	10.1
Thereafter	2,205.2
Total debt and capital lease obligations	$ 3,116.2

Long-term Debt - Textual (Detai

Long-term Debt - Textual (Details) - USD ($) $ in Millions	May. 06, 2016	Mar. 24, 2016	Jun. 30, 2016	Mar. 31, 2016	Mar. 31, 2015	Apr. 06, 2016	Feb. 23, 2016
Long Term Debt (Textual) [ Abstract]
Repayments of Long-term Debt				$ 56.3	$ 252.9
Loss on early extinguishment of debt				$ 2.4	$ 1.2
7.75% Senior Notes Due 2022 [Member]
Long Term Debt (Textual) [ Abstract]
Senior Notes, Portion of Principal Extinguished							$ 50
Senior Note, redemption price		103.875%
Repayments of Long-term Debt		$ 52
Debt Instrument, Interest Rate, Stated Percentage				7.75%
7.75% Senior Notes Due 2022 [Member] \| Subsequent Event [Member]
Long Term Debt (Textual) [ Abstract]
Senior Notes, Portion of Principal Extinguished						$ 50
Senior Note, redemption price	103.875%
5.125% Senior Notes Due 2023 [Member]
Long Term Debt (Textual) [ Abstract]
Debt Instrument, Interest Rate, Stated Percentage				5.125%
5.75% Senior Notes Due 2024 [Member]
Long Term Debt (Textual) [ Abstract]
Debt Instrument, Interest Rate, Stated Percentage				5.75%
5.75% Senior Notes Due 2025 [Member]
Long Term Debt (Textual) [ Abstract]
Debt Instrument, Interest Rate, Stated Percentage				5.75%
2.00% Convertible Senior Subordinated Notes due 2043 [Member]
Long Term Debt (Textual) [ Abstract]
Debt Instrument, Interest Rate, Stated Percentage				2.00%
Scenario, Forecast [Member]
Long Term Debt (Textual) [ Abstract]
Repayments of Long-term Debt	$ 52
Loss on early extinguishment of debt			$ 2

Redeemable Noncontrolling Int47

Redeemable Noncontrolling Interests - Table 1 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Redeemable Noncontrolling Interest [Line Items]
Balance at beginning of period	$ 121.1
Net Income attributable to noncontrolling interest	3.9	$ 2.9
Distributions declared	(17.1)	(12.4)
Change in fair value	16.3
Balance at end of period	96.2
Altoona, Jonesboro, and Encompass [Member]
Redeemable Noncontrolling Interest [Line Items]
Balance at beginning of period	121.1	84.7
Net Income attributable to noncontrolling interest	3.9	2.9
Balance at end of period	96.2	84.7
Altoona and Jonesboro [Member]
Redeemable Noncontrolling Interest [Line Items]
Distributions declared	(2.1)	(1.7)
Encompass [Member]
Redeemable Noncontrolling Interest [Line Items]
Change in fair value	$ (26.7)	$ (1.2)

Redeemable Noncontrolling Int48

Redeemable Noncontrolling Interests - Table 2 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Redeemable Noncontrolling Interest [Line Items]
Net income attributable to nonredeemable noncontrolling interest	$ 14.8	$ 13.6
Net income attributable to redeemable noncontrolling interest	3.9	2.9
Net income attributable to noncontrolling interests	$ 18.7	$ 16.5

Fair Value Measurements - Table

Fair Value Measurements - Table 1 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Redeemable Noncontrolling Interest, Fair Value	$ 96.2	$ 121.1
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Redeemable Noncontrolling Interest, Fair Value	0	0
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Redeemable Noncontrolling Interest, Fair Value	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Redeemable Noncontrolling Interest, Fair Value	96.2	121.1
Other Current Assets [Member] \| Restricted Marketable Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Marketable Securities, Fair Value	$ 16	$ 16.1
Fair Value Measurements, Valuation Techniques	M	M
Other Current Assets [Member] \| Restricted Marketable Securities [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Marketable Securities, Fair Value	$ 0	$ 0
Other Current Assets [Member] \| Restricted Marketable Securities [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Marketable Securities, Fair Value	16	16.1
Other Current Assets [Member] \| Restricted Marketable Securities [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Marketable Securities, Fair Value	0	0
Other Long-term Assets [Member] \| Restricted Marketable Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Marketable Securities, Fair Value	$ 40.7	$ 40.1
Fair Value Measurements, Valuation Techniques	M	M
Other Long-term Assets [Member] \| Restricted Marketable Securities [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Marketable Securities, Fair Value	$ 0	$ 0
Other Long-term Assets [Member] \| Restricted Marketable Securities [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Marketable Securities, Fair Value	40.7	40.1
Other Long-term Assets [Member] \| Restricted Marketable Securities [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Marketable Securities, Fair Value	$ 0	$ 0
Redeemable Noncontrolling Interest [Member]
Fair Value, Assets and Liabilities Measured on Recurring Basis [Abstract]
Fair Value Measurements, Valuation Techniques	I	I

Fair Value Measurements - Tab50

Fair Value Measurements - Table 2 (Details) - USD ($) $ in Millions	Mar. 31, 2016	Dec. 31, 2015
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Advances under revolving credit facility	$ 130	$ 130
Other notes payable	38.4	39.2
Revolving Credit Facility [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Advances under revolving credit facility	130	130
Revolving Credit Facility [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Advances under revolving credit facility, Fair Value	130	130
Term Loan Facilities [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Term loan facilities	437.8	443.3
Term Loan Facilities [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Term loan facilities, Fair Value	439.4	445
7.75% Senior Notes due 2022 [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes	124.8	174.3
7.75% Senior Notes due 2022 [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes	124.8	174.3
7.75% Senior Notes due 2022 [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes, Fair Value	131.5	183.7
5.125% Senior Notes Due 2023 [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes	294.8	294.6
5.125% Senior Notes Due 2023 [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes	294.8	294.6
5.125% Senior Notes Due 2023 [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes, Fair Value	298.9	288
5.75% Senior Notes Due 2024 [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes	1,192.7	1,192.6
5.75% Senior Notes Due 2024 [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes	1,192.7	1,192.6
5.75% Senior Notes Due 2024 [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes, Fair Value	1,218	1,146
5.75% Senior Notes Due 2025 [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes	343.5	343.4
5.75% Senior Notes Due 2025 [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes	343.5	343.4
5.75% Senior Notes Due 2025 [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Senior Notes, Fair Value	351.8	332.5
2.00% Convertible Senior Subordinated Notes due 2043 [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Convertible Subordinated Debt	268.3	265.9
2.00% Convertible Senior Subordinated Notes due 2043 [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Convertible Subordinated Debt	268.3	265.9
2.00% Convertible Senior Subordinated Notes due 2043 [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Convertible Debt, Fair Value	358.2	345
Other Notes Payable [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Other notes payable	38.4	39.2
Other Notes Payable [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Other Notes Payable, Fair Value	38.4	39.2
Letters of Credit [Member] \| Carrying Amount [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Letters of Credit	0	0
Letters of Credit [Member] \| Estimated Fair Value [Member]
Carrying Amounts and Estimated Fair Values, Financial Instruments [Abstract]
Letters of Credit, Fair Value	$ 35	$ 34.2

Fair Value Measurements Fair Va

Fair Value Measurements Fair Value Measurements - Textuals (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Fair Value, Measurements, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Option, Changes in Fair Value, Gain (Loss)	$ 0	$ 0

Share-Based Payments - Textual

Share-Based Payments - Textual (Details) shares in Millions	1 Months Ended
Share-Based Payments - Textual (Details) shares in Millions	Feb. 29, 2016shares
Restricted Stock [Member]
Share-based Compensation (Textual) [Abstract]
Restricted Stock Awards Issued	0.7
Restricted Stock Awards Issued, Service Requirement Only	0.2
Stock Options [Member]
Share-based Compensation (Textual) [Abstract]
Stock Options Granted	0.1

Income Taxes - Table (Details)

Income Taxes - Table (Details) $ in Millions	3 Months Ended
Income Taxes - Table (Details) $ in Millions	Mar. 31, 2016USD ($)
Gross Unrecognized Income Tax Benefits [Abstract]
Unrecognized Tax Benefits, Beginning Balance	$ 2.9
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions	0.1
Unrecognized Tax Benefits, Ending Balance	$ 3

Income Taxes - Textual (Details

Income Taxes - Textual (Details) - USD ($) $ in Millions	3 Months Ended
Income Taxes - Textual (Details) - USD ($) $ in Millions	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Income Tax Contingency [Line Items]
Provision for income tax expense	$ 39.7	$ 30.3
Net Deferred Tax Assets, Total	145
Deferred Tax Assets, Valuation Allowance	27.6
Gross Operating Loss Carryforwards	183
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	15.5
Gross Unrecognized Tax Benefits	3		$ 2.9
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	3		$ 2.9
Federal
Income Tax Contingency [Line Items]
Deferred Tax Assets, Net Operating Loss Carryforwards	64.1
Tax Credit Carryforward, Amount	15
Minimum [Member]
Income Tax Contingency [Line Items]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit	0.5
Maximum [Member]
Income Tax Contingency [Line Items]
Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit	$ 2.9

Earnings per Common Share - Tab

Earnings per Common Share - Table 1 (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Numerator:
Income from continuing operations	$ 76.8	$ 59.3
Less: Net income attributable to noncontrolling interests included in continuing operations	(18.7)	(16.5)
Less: Income allocated to participating securities	(0.2)	(0.3)
Less: Convertible perpetual preferred stock dividends	0	(1.6)
Income from continuing operations attributable to HealthSouth common shareholders	57.9	40.9
Loss from discontinued operations, net of tax	(0.1)	(0.3)
Net income attributable to HealthSouth common shareholders	$ 57.8	$ 40.6
Denominator:
Basic weighted average common shares outstanding	89.5	87.1
Basic earnings per share attributable to HealthSouth common shareholders:
Continuing operations	$ 0.65	$ 0.47
Discontinued operations	0	0
Net Income	$ 0.65	$ 0.47
Numerator
Income from continuing operations	$ 76.8	$ 59.3
Less: Net income attributable to noncontrolling interests included in continuing operations	(18.7)	(16.5)
Add: Interest on convertible debt, net of tax	2.4	2.3
Income from continuing operations attributable to HealthSouth common shareholders	60.5	45.1
Loss from discontinued operations, net of tax	(0.1)	(0.3)
Net income attributable to HealthSouth common shareholders	$ 60.4	$ 44.8
Denominator
Diluted weighted average common shares outstanding	99.4	101.1
Diluted earnings per share attributable to HealthSouth common shareholders:
Continuing operations	$ 0.61	$ 0.44
Discontinued operations	0	0
Net Income	$ 0.61	$ 0.44

Earnings per Common Share - T56

Earnings per Common Share - Table 2 (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Earnings Per Share [Abstract]
Basic weighted average common shares outstanding	89.5	87.1
Convertible perpetual preferred stock	0	3.2
Convertible senior subordinated notes	8.4	8.2
Restricted stock awards, dilutive stock options, restricted stock units, and common stock warrants	1.5	2.6
Diluted weighted average common shares outstanding	99.4	101.1

Earnings per Common Share - Tex

Earnings per Common Share - Textual (Details) - USD ($) $ / shares in Units, $ in Millions	Oct. 23, 2015	Apr. 30, 2016	Feb. 29, 2016	Jan. 31, 2016	Mar. 31, 2016	Mar. 31, 2015	Apr. 01, 2016	Dec. 31, 2015
Earnings per Common Share (Textual) [Abstract]
Cash dividends per common share, Declared					$ 0.23	$ 0.21
Common Stock
Earnings per Common Share (Textual) [Abstract]
Cash dividends per common share, Declared	$ 0.23		$ 0.23
Cash dividends per common share, Paid				$ 0.23
Dividends Payable, Current					$ 21.2			$ 21.3
2.00% Convertible Senior Subordinated Notes due 2043 [Member]
Earnings per Common Share (Textual) [Abstract]
Debt Instrument, Convertible, Conversion Price					$ 39.65
Debt Instrument, Convertible, Terms of Conversion Feature					25.2194 shares per $1,000 principal amount
Subsequent Event [Member] \| Common Stock
Earnings per Common Share (Textual) [Abstract]
Cash dividends per common share, Paid		$ 0.23
Subsequent Event [Member] \| 2.00% Convertible Senior Subordinated Notes due 2043 [Member]
Earnings per Common Share (Textual) [Abstract]
Debt Instrument, Convertible, Conversion Price							$ 37.59
Debt Instrument, Convertible, Shares Issued Upon Conversion							26.6011

Contingencies and Other Commi58

Contingencies and Other Commitments (Details) - HHS-OIG Investigation [Member]	Mar. 31, 2016	Feb. 28, 2015	Apr. 24, 2014	Mar. 04, 2013
Contingencies (Textual) [Abstract]
Number of hospitals that received subpoenas			7	4
Number of patient medical records requested for each hospital in subpoenas				100
Number of hospitals that received supplemental subpoenas			2
Number of additional patient medical records requested		70
Compliance Threshold Under Health Care Act	60.00%

Segment Reporting Segment Rep59

Segment Reporting Segment Reporting - Table 1 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Net operating revenues	$ 909.8	$ 740.6
Provision for Doubtful Accounts	(16.5)	(11.6)
Net operating revenues less provision for doubtful accounts	893.3	729
Costs and Expenses [Abstract]
Salaries and benefits	486.1	385.1
Other operating expenses	119.2	103.2
Supplies	35	31.4
Occupancy costs	18	12.1
Total segment level operating expenses	732.8	608.5
Other income	(0.6)	(0.5)
Equity in net income of nonconsolidated affiliates	(2.4)	(1.6)
Noncontrolling interest	(18.7)	(16.5)
Inpatient Rehabilitation Hospital [Member]
Segment Reporting Information [Line Items]
Net operating revenues	749.2	630.3
Provision for Doubtful Accounts	(15.6)	(11)
Net operating revenues less provision for doubtful accounts	733.6	619.3
Costs and Expenses [Abstract]
Salaries and benefits	369.9	306.4
Other operating expenses	104.8	95.2
Supplies	32.4	29.8
Occupancy costs	15.6	10.4
Total segment level operating expenses	522.7	441.8
Other income	(0.6)	(0.5)
Equity in net income of nonconsolidated affiliates	(2.2)	(1.6)
Noncontrolling interest	16.8	15.2
Segment Adjusted EBITDA	196.9	164.4
Capital Expenditures	38.7	26.3
Home Health and Hospice [Member]
Segment Reporting Information [Line Items]
Net operating revenues	160.6	110.3
Provision for Doubtful Accounts	(0.9)	(0.6)
Net operating revenues less provision for doubtful accounts	159.7	109.7
Costs and Expenses [Abstract]
Cost of services sold (excluding depreciation and amortization)	78.4	53.4
Support and overhead costs	57	38.1
Total segment level operating expenses	135.4	91.5
Other income	0	0
Equity in net income of nonconsolidated affiliates	(0.2)	0
Noncontrolling interest	1.9	1.3
Segment Adjusted EBITDA	22.6	16.9
Capital Expenditures	$ 0.4	$ 0.3

Segment Reporting Segment Rep60

Segment Reporting Segment Reporting - Table 2 (Details) - USD ($) $ in Millions	Mar. 31, 2016		Dec. 31, 2015
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	$ 4,608.3	[1]	$ 4,606.1
Investments in and advances to nonconsolidated affiliates	12.5		11.7
Inpatient Rehabilitation Hospital [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	3,583.1		3,589
Investments in and advances to nonconsolidated affiliates	9.9		9.3
Home Health and Hospice [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets	1,096.5		1,088.4
Investments in and advances to nonconsolidated affiliates	$ 2.6		$ 2.4

[1]	(1) Our consolidated assets as of March 31, 2016 include total assets of variable interest entities of $247.3 million, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of March 31, 2016 include total liabilities of the variable interest entities of $54.0 million. See Note 3, Variable Interest Entities.

Segment Reporting Segment Rep61

Segment Reporting Segment Reporting - Table 3 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
General and administrative expenses	$ (31.9)	$ (34.6)
Depreciation and amortization	(42.4)	(31.9)
(Loss) gain on disposal or impairment of assets	(0.2)	1.5
Government, class action, and related settlements	0	(8)
Professional fees - accounting, tax, and legal	(0.2)	(2.2)
Loss on early extinguishment of debt	(2.4)	(1.2)
Interest expense and amortization of debt discounts and fees	(44.6)	(31.8)
Net income attributable to noncontrolling interests	18.7	16.5
Income from continuing operations before income tax expense	116.5	89.6
Inpatient Rehabilitation Hospital and Home Health and Hospice [Member]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total segment Adjusted EBITDA	$ 219.5	$ 181.3

Segment Reporting Segment Rep62

Segment Reporting Segment Reporting - Table 4 (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2016		Dec. 31, 2015
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets for reportable segments	$ 4,608.3	[1]	$ 4,606.1
Reclassification of noncurrent deferred income tax liabilities to net noncurrent deferred income tax assets	(71.3)		(71.3)
Total assets	4,608.3	[1]	4,606.1
Inpatient Rehabilitation Hospital and Home Health and Hospice [Member]
Segment Reporting, Asset Reconciling Item [Line Items]
Total assets for reportable segments	4,679.6		4,677.4
Total assets	$ 4,679.6		$ 4,677.4

[1]	(1) Our consolidated assets as of March 31, 2016 include total assets of variable interest entities of $247.3 million, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of March 31, 2016 include total liabilities of the variable interest entities of $54.0 million. See Note 3, Variable Interest Entities.

Segment Reporting Segment Rep63

Segment Reporting Segment Reporting - Table 5 (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Segment Reporting, Revenue Reconciling Item [Line Items]
Net operating revenues	$ 909.8	$ 740.6
Inpatient Rehabilitation Hospital [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net operating revenues	749.2	630.3
Inpatient [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net operating revenues	719.4	606.6
Outpatient and other [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net operating revenues	29.8	23.7
Home Health and Hospice [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net operating revenues	160.6	110.3
Home health [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net operating revenues	150.9	103.9
Hospice [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Net operating revenues	$ 9.7	$ 6.4

Segment Reporting Segment Rep64

Segment Reporting Segment Reporting - Textuals (Details)	Mar. 31, 2016facilities
Inpatient Rehabilitation Hospital [Member]
Segment Reporting Information [Line Items]
Number of States in which Entity Operates	29
Number of Inpatient Rehabilitation Hospitals	122
Number of Joint Venture Hospitals Accounted for Using the Equity Method	1
Number of Inpatient Rehabilitation Units Under Management Contracts	4
Home Health and Hospice [Member]
Segment Reporting Information [Line Items]
Number of States in which Entity Operates	24
Number of Hospital Based Home Health and Hospice Agencies	213
Number of Joint Venture Agencies Accounted for Using the Equity Method	2

Condensed Consolidating Finan65

Condensed Consolidating Financial Information - Income Statement Tables (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Condensed Consolidating Statements of Operations
Net operating revenues	$ 909.8	$ 740.6
Less: Provision for doubtful accounts	(16.5)	(11.6)
Net operating revenues less provision for doubtful accounts	893.3	729
Operating expenses:
Salaries and benefits	486.1	385.1
Other operating expenses	119.2	103.2
Occupancy costs	18	12.1
Supplies	35	31.4
General and administrative expenses	31.9	34.6
Depreciation and amortization	42.4	31.9
Government, class action, and related settlements	0	8
Professional fees - accounting, tax, and legal	0.2	2.2
Total operating expenses	732.8	608.5
Loss on early extinguishment of debt	2.4	1.2
Interest expense and amortization of debt discounts and fees	44.6	31.8
Other income	(0.6)	(0.5)
Equity in net income of nonconsolidated affiliates	(2.4)	(1.6)
Equity in net income of consolidated affiliates	0	0
Management fees	0	0
Income from continuing operations before income tax expense	116.5	89.6
Provision for income tax (benefit) expense	39.7	30.3
Income from continuing operations	76.8	59.3
Loss from discontinued operations, net of tax	(0.1)	(0.3)
Net income	76.7	59
Less: Net income attributable to noncontrolling interests	(18.7)	(16.5)
Net income attributable to HealthSouth	58	42.5
Comprehensive income	76.8	59.1
Comprehensive income attributable to HealthSouth	58.1	42.6
HealthSouth Corporation [Member]
Condensed Consolidating Statements of Operations
Net operating revenues	4.9	5.3
Less: Provision for doubtful accounts	0	0
Net operating revenues less provision for doubtful accounts	4.9	5.3
Operating expenses:
Salaries and benefits	11.3	8.1
Other operating expenses	5.4	9.5
Occupancy costs	0.9	1.1
Supplies	0	0
General and administrative expenses	33.2	34.3
Depreciation and amortization	2.4	2.3
Government, class action, and related settlements		8
Professional fees - accounting, tax, and legal	0.2	2.2
Total operating expenses	53.4	65.5
Loss on early extinguishment of debt	2.4	1.2
Interest expense and amortization of debt discounts and fees	38.9	29.2
Other income	(4.7)	(2.3)
Equity in net income of nonconsolidated affiliates	0	0
Equity in net income of consolidated affiliates	(86.2)	(78.6)
Management fees	(34.2)	(28.5)
Income from continuing operations before income tax expense	35.3	18.8
Provision for income tax (benefit) expense	(22.8)	(24)
Income from continuing operations	58.1	42.8
Loss from discontinued operations, net of tax	(0.1)	(0.3)
Net income	58	42.5
Less: Net income attributable to noncontrolling interests	0	0
Net income attributable to HealthSouth	58	42.5
Comprehensive income	58.1	42.6
Comprehensive income attributable to HealthSouth	58.1	42.6
Guarantor Subsidiaries [Member]
Condensed Consolidating Statements of Operations
Net operating revenues	550.7	456.8
Less: Provision for doubtful accounts	(11.9)	(9)
Net operating revenues less provision for doubtful accounts	538.8	447.8
Operating expenses:
Salaries and benefits	255	211.1
Other operating expenses	77.1	63.1
Occupancy costs	23	15.3
Supplies	23.2	20.8
General and administrative expenses	0	0
Depreciation and amortization	25.7	19.1
Government, class action, and related settlements		0
Professional fees - accounting, tax, and legal	0	0
Total operating expenses	404	329.4
Loss on early extinguishment of debt	0	0
Interest expense and amortization of debt discounts and fees	5.2	2.3
Other income	(0.1)	0
Equity in net income of nonconsolidated affiliates	(2.1)	(1.6)
Equity in net income of consolidated affiliates	(8.2)	(8.1)
Management fees	26.2	21.7
Income from continuing operations before income tax expense	113.8	104.1
Provision for income tax (benefit) expense	45.4	39.6
Income from continuing operations	68.4	64.5
Loss from discontinued operations, net of tax	0	0
Net income	68.4	64.5
Less: Net income attributable to noncontrolling interests	0	0
Net income attributable to HealthSouth	68.4	64.5
Comprehensive income	68.4	64.5
Comprehensive income attributable to HealthSouth	68.4	64.5
Nonguarantor Subsidiaries [Member]
Condensed Consolidating Statements of Operations
Net operating revenues	383.2	303.2
Less: Provision for doubtful accounts	(4.6)	(2.6)
Net operating revenues less provision for doubtful accounts	378.6	300.6
Operating expenses:
Salaries and benefits	224.4	170
Other operating expenses	47.8	41
Occupancy costs	7.4	5.9
Supplies	11.8	10.6
General and administrative expenses	(1.3)	0.3
Depreciation and amortization	14.3	10.5
Government, class action, and related settlements		0
Professional fees - accounting, tax, and legal	0	0
Total operating expenses	304.4	238.3
Loss on early extinguishment of debt	0	0
Interest expense and amortization of debt discounts and fees	5.3	2.7
Other income	(0.6)	(0.6)
Equity in net income of nonconsolidated affiliates	(0.3)	0
Equity in net income of consolidated affiliates	0	0
Management fees	8	6.8
Income from continuing operations before income tax expense	61.8	53.4
Provision for income tax (benefit) expense	17.1	14.7
Income from continuing operations	44.7	38.7
Loss from discontinued operations, net of tax	0	0
Net income	44.7	38.7
Less: Net income attributable to noncontrolling interests	(18.7)	(16.5)
Net income attributable to HealthSouth	26	22.2
Comprehensive income	44.7	38.7
Comprehensive income attributable to HealthSouth	26	22.2
Eliminating Entries [Member]
Condensed Consolidating Statements of Operations
Net operating revenues	(29)	(24.7)
Less: Provision for doubtful accounts	0	0
Net operating revenues less provision for doubtful accounts	(29)	(24.7)
Operating expenses:
Salaries and benefits	(4.6)	(4.1)
Other operating expenses	(11.1)	(10.4)
Occupancy costs	(13.3)	(10.2)
Supplies	0	0
General and administrative expenses	0	0
Depreciation and amortization	0	0
Government, class action, and related settlements		0
Professional fees - accounting, tax, and legal	0	0
Total operating expenses	(29)	(24.7)
Loss on early extinguishment of debt	0	0
Interest expense and amortization of debt discounts and fees	(4.8)	(2.4)
Other income	4.8	2.4
Equity in net income of nonconsolidated affiliates	0	0
Equity in net income of consolidated affiliates	94.4	86.7
Management fees	0	0
Income from continuing operations before income tax expense	(94.4)	(86.7)
Provision for income tax (benefit) expense	0	0
Income from continuing operations	(94.4)	(86.7)
Loss from discontinued operations, net of tax	0	0
Net income	(94.4)	(86.7)
Less: Net income attributable to noncontrolling interests	0	0
Net income attributable to HealthSouth	(94.4)	(86.7)
Comprehensive income	(94.4)	(86.7)
Comprehensive income attributable to HealthSouth	$ (94.4)	$ (86.7)

Condensed Consolidating Finan66

Condensed Consolidating Financial Information - Balance Sheet Tables (Details) - USD ($) $ in Millions	Mar. 31, 2016		Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 73.2		$ 61.6	$ 208.3	$ 66.7
Accounts receivable, net	431.9		410.5
Other current assets	127		126.6
Total current assets	632.1		598.7
Property and equipment, net	1,317.7		1,310.1
Goodwill	1,891.9		1,890.1
Intangible assets, net	415.8		419.4
Deferred income tax assets	145		190.8
Other long-term assets	205.8		197
Intercompany notes receivable	0		0
Intercompany receivable and investments in consolidated affiliates	0		0
Total assets	4,608.3	[1]	4,606.1
Current liabilities:
Current portion of long-term debt	36.6		36.8
Accounts payable	62.7		61.6
Accrued expenses and other current liabilities	364.5		328
Total current liabilities	463.8		426.4
Long-term debt, net of current portion	3,079.6		3,134.7
Intercompany notes payable	0		0
Other long-term liabilities	144.8		144.6
Intercompany payable	0		0
Total Liabilities	$ 3,688.2		$ 3,705.7
Commitments and contingencies
Redeemable noncontrolling interests	$ 96.2		$ 121.1
Shareholders' equity:
HealthSouth shareholders’ equity	649.5		611.4
Noncontrolling interests	174.4		167.9
Total shareholders' equity	823.9		779.3	640.4	619.5
Total liabilities and shareholders' equity	4,608.3	[1]	4,606.1
HealthSouth Corporation [Member]
Current assets:
Cash and cash equivalents	47.8		41.2	189.6	41.9
Accounts receivable, net	0		0
Other current assets	59.1		29.3
Total current assets	106.9		70.5
Property and equipment, net	15.8		14.5
Goodwill	0		0
Intangible assets, net	11.2		8.8
Deferred income tax assets	131.3		176.2
Other long-term assets	48.2		48.6
Intercompany notes receivable	541.3		546.6
Intercompany receivable and investments in consolidated affiliates	2,802		2,779.7
Total assets	3,656.7		3,644.9
Current liabilities:
Current portion of long-term debt	40.1		40
Accounts payable	6		5.8
Accrued expenses and other current liabilities	151.3		122.2
Total current liabilities	197.4		168
Long-term debt, net of current portion	2,769.7		2,821.9
Intercompany notes payable	0		0
Other long-term liabilities	40.1		43.6
Intercompany payable	0		0
Total Liabilities	$ 3,007.2		$ 3,033.5
Commitments and contingencies
Redeemable noncontrolling interests	$ 0		$ 0
Shareholders' equity:
HealthSouth shareholders’ equity	649.5		611.4
Noncontrolling interests	0		0
Total shareholders' equity	649.5		611.4
Total liabilities and shareholders' equity	3,656.7		3,644.9
Guarantor Subsidiaries [Member]
Current assets:
Cash and cash equivalents	2.7		1.3	1	1.5
Accounts receivable, net	277.7		267.2
Other current assets	21.6		22.7
Total current assets	302		291.2
Property and equipment, net	960.5		965.7
Goodwill	863.2		863.2
Intangible assets, net	122		123.2
Deferred income tax assets	63.2		64.1
Other long-term assets	81		75.3
Intercompany notes receivable	0		0
Intercompany receivable and investments in consolidated affiliates	0		0
Total assets	2,391.9		2,382.7
Current liabilities:
Current portion of long-term debt	6.6		6.8
Accounts payable	38.2		35.2
Accrued expenses and other current liabilities	90.4		72.6
Total current liabilities	135.2		114.6
Long-term debt, net of current portion	254		255.6
Intercompany notes payable	0		0
Other long-term liabilities	14.3		12.4
Intercompany payable	42.5		141.7
Total Liabilities	$ 446		$ 524.3
Commitments and contingencies
Redeemable noncontrolling interests	$ 0		$ 0
Shareholders' equity:
HealthSouth shareholders’ equity	1,945.9		1,858.4
Noncontrolling interests	0		0
Total shareholders' equity	1,945.9		1,858.4
Total liabilities and shareholders' equity	2,391.9		2,382.7
Nonguarantor Subsidiaries [Member]
Current assets:
Cash and cash equivalents	22.7		19.1	17.7	23.3
Accounts receivable, net	154.2		143.3
Other current assets	127.5		93.4
Total current assets	304.4		255.8
Property and equipment, net	341.4		329.9
Goodwill	1,028.7		1,026.9
Intangible assets, net	282.6		287.4
Deferred income tax assets	0		0
Other long-term assets	76.6		73.1
Intercompany notes receivable	0		0
Intercompany receivable and investments in consolidated affiliates	0		0
Total assets	2,033.7		1,973.1
Current liabilities:
Current portion of long-term debt	7.4		7.5
Accounts payable	18.5		20.6
Accrued expenses and other current liabilities	186.5		134.5
Total current liabilities	212.4		162.6
Long-term debt, net of current portion	55.9		57.2
Intercompany notes payable	541.3		546.6
Other long-term liabilities	139.6		137.7
Intercompany payable	176.9		179.1
Total Liabilities	$ 1,126.1		$ 1,083.2
Commitments and contingencies
Redeemable noncontrolling interests	$ 96.2		$ 121.1
Shareholders' equity:
HealthSouth shareholders’ equity	637		600.9
Noncontrolling interests	174.4		167.9
Total shareholders' equity	811.4		768.8
Total liabilities and shareholders' equity	2,033.7		1,973.1
Eliminating Entries [Member]
Current assets:
Cash and cash equivalents	0		0	$ 0	$ 0
Accounts receivable, net	0		0
Other current assets	(81.2)		(18.8)
Total current assets	(81.2)		(18.8)
Property and equipment, net	0		0
Goodwill	0		0
Intangible assets, net	0		0
Deferred income tax assets	(49.5)		(49.5)
Other long-term assets	0		0
Intercompany notes receivable	(541.3)		(546.6)
Intercompany receivable and investments in consolidated affiliates	(2,802)		(2,779.7)
Total assets	(3,474)		(3,394.6)
Current liabilities:
Current portion of long-term debt	(17.5)		(17.5)
Accounts payable	0		0
Accrued expenses and other current liabilities	(63.7)		(1.3)
Total current liabilities	(81.2)		(18.8)
Long-term debt, net of current portion	0		0
Intercompany notes payable	(541.3)		(546.6)
Other long-term liabilities	(49.2)		(49.1)
Intercompany payable	(219.4)		(320.8)
Total Liabilities	$ (891.1)		$ (935.3)
Commitments and contingencies
Redeemable noncontrolling interests	$ 0		$ 0
Shareholders' equity:
HealthSouth shareholders’ equity	(2,582.9)		(2,459.3)
Noncontrolling interests	0		0
Total shareholders' equity	(2,582.9)		(2,459.3)
Total liabilities and shareholders' equity	$ (3,474)		$ (3,394.6)

[1]	(1) Our consolidated assets as of March 31, 2016 include total assets of variable interest entities of $247.3 million, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of March 31, 2016 include total liabilities of the variable interest entities of $54.0 million. See Note 3, Variable Interest Entities.

Condensed Consolidating Finan67

Condensed Consolidating Financial Information - Cash Flow Statement Tables (Details) $ in Millions	3 Months Ended
	Mar. 31, 2016USD ($)	Mar. 31, 2015USD ($)
Condensed Consolidating Statements of Cash Flows
Net cash provided by operating activities	$ 159.7	$ 102
Cash flows from investing activities:
Purchases of property and equipment	(31.4)	(17.7)
Capitalized software costs	(7.7)	(8.9)
Acquisition of business, net of cash acquired	0	(7.3)
Net change in restricted cash	(3.2)	(15)
Proceeds from repayment of intercompany notes receivable	0
Other	2.8	3.2
Net cash used in investing activities	(39.5)	(45.7)
Cash flows from financing activities:
Proceeds from bond issuance	0	700
Principal payments on debt, including pre-payments	(56.3)	(252.9)
Repayments of Related Party Debt	0
Borrowings on revolving credit facility	60	35
Payments on revolving credit facility	(60)	(350)
Debt amendment and issuance costs	0	(13.7)
Repurchase of common stock, including fees and expenses	(12.9)	0
Dividends paid on common stock	(21.3)	(18.6)
Dividends paid on convertible perpetual preferred stock	0	(1.6)
Distributions paid to noncontrolling interests of consolidated affiliates	(15.6)	(13.2)
Other	(2.5)	0.3
Change in intercompany advances	0	0
Net cash (used in) provided by financing activities	(108.6)	85.3
Increase (decrease) in cash and cash equivalents	11.6	141.6
Cash and cash equivalents at beginning of period	61.6	66.7
Cash and cash equivalents at end of period	$ 73.2	208.3
Condensed Consolidating Financial Information (Textual) [Abstract]
HealthSouth ownership percentage of subsidiary guarantors	100.00%
Senior secured leverage ratio maximum	1.75
Consolidated coverage ratio minimum	2
HealthSouth Corporation [Member]
Condensed Consolidating Statements of Cash Flows
Net cash provided by operating activities	$ 4	6.6
Cash flows from investing activities:
Purchases of property and equipment	(3.2)	(2.4)
Capitalized software costs	(7.7)	(8.8)
Acquisition of business, net of cash acquired		0
Net change in restricted cash	0	0
Proceeds from repayment of intercompany notes receivable	5
Other	0	0
Net cash used in investing activities	(5.9)	(11.2)
Cash flows from financing activities:
Proceeds from bond issuance		700
Principal payments on debt, including pre-payments	(55.6)	(252.5)
Repayments of Related Party Debt	0
Borrowings on revolving credit facility	60	35
Payments on revolving credit facility	(60)	(350)
Debt amendment and issuance costs		(13.7)
Repurchase of common stock, including fees and expenses	(12.9)
Dividends paid on common stock	(21.3)	(18.6)
Dividends paid on convertible perpetual preferred stock		(1.6)
Distributions paid to noncontrolling interests of consolidated affiliates	0	0
Other	0.3	1.7
Change in intercompany advances	98	52
Net cash (used in) provided by financing activities	8.5	152.3
Increase (decrease) in cash and cash equivalents	6.6	147.7
Cash and cash equivalents at beginning of period	41.2	41.9
Cash and cash equivalents at end of period	47.8	189.6
Guarantor Subsidiaries [Member]
Condensed Consolidating Statements of Cash Flows
Net cash provided by operating activities	93.4	53
Cash flows from investing activities:
Purchases of property and equipment	(13.4)	(8.2)
Capitalized software costs	0	0
Acquisition of business, net of cash acquired		0
Net change in restricted cash	0	0
Proceeds from repayment of intercompany notes receivable	0
Other	(0.3)	3.5
Net cash used in investing activities	(13.7)	(4.7)
Cash flows from financing activities:
Proceeds from bond issuance		0
Principal payments on debt, including pre-payments	(0.4)	(0.4)
Repayments of Related Party Debt	0
Borrowings on revolving credit facility	0	0
Payments on revolving credit facility	0	0
Debt amendment and issuance costs		0
Repurchase of common stock, including fees and expenses	0
Dividends paid on common stock	0	0
Dividends paid on convertible perpetual preferred stock		0
Distributions paid to noncontrolling interests of consolidated affiliates	0	0
Other	(1.4)	(0.6)
Change in intercompany advances	(76.5)	(47.8)
Net cash (used in) provided by financing activities	(78.3)	(48.8)
Increase (decrease) in cash and cash equivalents	1.4	(0.5)
Cash and cash equivalents at beginning of period	1.3	1.5
Cash and cash equivalents at end of period	2.7	1
Nonguarantor Subsidiaries [Member]
Condensed Consolidating Statements of Cash Flows
Net cash provided by operating activities	62.4	42.4
Cash flows from investing activities:
Purchases of property and equipment	(14.8)	(7.1)
Capitalized software costs	0	(0.1)
Acquisition of business, net of cash acquired		(7.3)
Net change in restricted cash	(3.2)	(15)
Proceeds from repayment of intercompany notes receivable	0
Other	3.1	(0.3)
Net cash used in investing activities	(14.9)	(29.8)
Cash flows from financing activities:
Proceeds from bond issuance		0
Principal payments on debt, including pre-payments	(0.3)	0
Repayments of Related Party Debt	(5)
Borrowings on revolving credit facility	0	0
Payments on revolving credit facility	0	0
Debt amendment and issuance costs		0
Repurchase of common stock, including fees and expenses	0
Dividends paid on common stock	0	0
Dividends paid on convertible perpetual preferred stock		0
Distributions paid to noncontrolling interests of consolidated affiliates	(15.6)	(13.2)
Other	(1.4)	(0.8)
Change in intercompany advances	(21.6)	(4.2)
Net cash (used in) provided by financing activities	(43.9)	(18.2)
Increase (decrease) in cash and cash equivalents	3.6	(5.6)
Cash and cash equivalents at beginning of period	19.1	23.3
Cash and cash equivalents at end of period	22.7	17.7
Eliminating Entries [Member]
Condensed Consolidating Statements of Cash Flows
Net cash provided by operating activities	(0.1)	0
Cash flows from investing activities:
Purchases of property and equipment	0	0
Capitalized software costs	0	0
Acquisition of business, net of cash acquired		0
Net change in restricted cash	0	0
Proceeds from repayment of intercompany notes receivable	(5)
Other	0	0
Net cash used in investing activities	(5)	0
Cash flows from financing activities:
Proceeds from bond issuance		0
Principal payments on debt, including pre-payments	0	0
Repayments of Related Party Debt	5
Borrowings on revolving credit facility	0	0
Payments on revolving credit facility	0	0
Debt amendment and issuance costs		0
Repurchase of common stock, including fees and expenses	0
Dividends paid on common stock	0	0
Dividends paid on convertible perpetual preferred stock		0
Distributions paid to noncontrolling interests of consolidated affiliates	0	0
Other	0	0
Change in intercompany advances	0.1	0
Net cash (used in) provided by financing activities	5.1	0
Increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	$ 0	$ 0